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ABSTRACT
The purpose of the study was to measure the responses of chronic obstructive
pulmonary disease patients to an exercise programme in a South Africa setting. Nine
subjects were evaluated before and after aerobic and resistance training three times a
week for the total of 12 weeks. Each evaluation measured forced expiratory lung
function; health-related quality of life; functional capacity; level of dyspnea; body
composition; physician global evaluation; and the patient global evaluation. The
exercise programme consisted of one-hour exercise sessions, three times a week for 12
weeks. The exercise sessions included elements of aerobic and resistance training of
the upper and lower extremities. Functional capacity improved drastically (p < 0.01),
as did the physician and the patient global evaluations (p < 0.01 and p < 0.01,
respectively). Levels of dyspnea also improved (p < 0.01). Health-related quality of
life improved marginally (p = 0.03). No significant change was noted in lung function
and body composition. The study concluded that an exercise programme consisting of
aerobic and resistance training improves chronic obstructive pulmonary disease
patients' health-related quality of life, functional capacity and levels of dyspnea.
Exercise also reduces the symptoms of chronic obstructive pulmonary disease as are
perceived by the physician and patient alike. Exercise does not change lung function or
body composition of chronic obstructive pulmonary disease patients. Exercise in
conjunction with appropriate medical treatment has the potential to benefit all chronic
obstructive patients in South Africa.
Keywords: COPD, quality oflife, functional capacity, rehabilitation, exercise.
Stellenbosch University http://scholar.sun.ac.za
11
OPSOMMING
Die doel van die studie was om die reaksies te meet van pasiënte met chroniese
obstruktiewe pulmonêre siekte op 'n oefenprogram in 'n Suid-Afrikaanse konteks.
Nege proefpersone is voor en na aërobiese en weerstandsoefening drie keer per week
vir 'n totaal van 12 weke geëvalueer. Elke evaluering het die volgende gemeet:
geforseerde ekspiratoriese longfunksie, gesondheidsverwante lewenskwalitiet,
funksionele kapasiteit; dispneevlak, liggaamsamestelling; geneesheer algehele
evaluering asook pasiënt algehele evaluering. Die oefenprogram het uit een-uur sessies
bestaan, wat drie keer per week vir 12 weke plaasgevind het. Die oefensessies het
elemente van aërobiese en weerstandsoefeninge van die boonste en onderste ledemate
ingesluit. Funksionele kapasiteit het drasties verbeter (p < 0.01), net so ook die
geneesheer en pasiënt algehele evaluerings (p < 0.01 en p < 0.01, respektiewelik).
Dispneevlakke het ook verbeter (p < 0.01). Gesondheidsverwante lewenskwaliteit het
marginaal verbeter (p = 0.03). Geen beduidende veranderinge is in die longfunksie en
liggaamsamestelling gevind nie. Die studie het bevind dat 'n oefenprogram wat uit
aërobiese en weerstandsoefening bestaan gesondheidsverwante lewenskwaliteit,
funksionele kapasiteit asook dispneevlakke van pasiënte met chroniese obstruktiewe
pulmonêre siekte verbeter. Oefening verminder ook die simptome van chroniese
obstruktiewe pulmonêre siekte soos waargeneem deur beide die geneesheer en pasiënt.
Oefening verander ook nie longfunksie of liggaamsamestelling van pasiënte met
chroniese obstruktiewe pulmonêre siekte nie. Oefening tesame met die geskikte
mediese behandeling kan voordelig wees vir chronies obstruktiewe pasiënte in Suid-
Afrika.
Keywords: KOPS, lewenskwaliteit, funksionele kapasiteit, rehabilitasie, oefening.
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CHAPTER ONE: INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and
mortality throughout the world (Curtis, Deyo & Hudson, 1994:162; Global Initiative for
Chronic Obstructive Pulmonary Disease (GOLD), 2001a; Pauwels et al., 2001: 1257;
Lundback et al., 2003:115; Barnes, 2003:87). In 1990 COPD was the sixth leading cause of
death in the world, responsible for more than two million or 4% of deaths (Lundback et al.,
2003: 115). By 2020 COPD will be the fourth leading cause of death worldwide being
superseded only by heart disease, cerebrovascular disease and cancer (GOLD, 2003). COPD
will share fourth place with Human Immunodeficiency Virus (HIV)/Acquired
Immunodeficiency Syndrome (AIDS) (GOLD, 2002). Whereas the first three conditions are
declining in prevalence, COPD is on the increase and will maintain this trend until 2020
(GOLD, 2001a). "By 2020, the mortality is expected to increase to 4-5 million, or 7% of all
deaths" (Lundback et al., 2003: 115). "According to the statistics produced by the American
Lung Association, 15 million Americans suffer from COPD and it claimed the lives of 87,
000 Americans in 1992" (Mak, n.d). In the United Kingdom it is estimated that 18% of males
and 14% of females aged 40-68 years have developed features of COPD, and in the USA,
13,6% of males and 11,8% of females aged 65-74 years are thought to have COPD (Mak,
n.d.). The prevalence of COPD is extremely high but it is thought that the figures are
distorted and reflect far lower totals than those, which are actually true (Lundback et al.,
2003: 115-116). "The substantial increase in the global burden of COPD projected over the
next 20 years reflects, in large part, the increasing use of tobacco worldwide, and the
changing age structure of populations in developing countries" (GOLD, 200 1b). National
figures for South Africa do not exist but a high prevalence of risk factors such as tuberculosis
(TB), childhood lung disease and "particularly a high smoking prevalence of 24% in our
population could make our country a Mecca for COPD" (GOLD, 2002)
Tobacco smoking carries the highest risk for COPD. Fifty percent (50%) of all smokers
develop COPD (Lundback et al., 2003:119), and 75% of deaths from chronic bronchitis and
emphysema are attributable to tobacco smoking (World Health Organization (WHO),
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21999:66). The WHO estimates that about 500 million people today will eventually be killed
by tobacco smoke (WHO, 1999:65). On current smoking patterns, the WHO estimates that
by the third decade of the 21st century, smoking is expected to kill 10million people annually
worldwide - more than the total deaths from malaria, maternal and major childhood
conditions, and tuberculosis combined (WHO, 1999:67). Not only are smokers affected, but
also exposure to other people's smoking is associated with a somewhat higher risk of lung
cancer, amongst several other important ailments (WHO, 1999:66). Consequently the
economic burden of tobacco smoking is enormous. Tobacco industries may derive great
economic benefits, "however, economic analyses conclude that even with highly conservative
assumptions, the economic costs of tobacco exceed its estimated benefits" (WHO, 1999: 68).
An analysis which estimated the additional costs (in mortality and health care) and the
benefits (to consumers and producers) per year if global tobacco production were to increase
by 1000 metric tons, concluded that there would be net economic losses of 13,6 million
dollars per year (WHO, 1999:68).
"Because COPD is highly prevalent and can be severely disabling, direct medical
expenditures and the indirect costs of morbidity and premature mortality from COPD
can represent a substantial economic and social burden for societies and public and
private insurance payers worldwide." (GOLD,2001b)
"By the year 2020, COPD will be fifth among the conditions that will be the highest burden to
society on a worldwide scale" (Hurd, 2000: 1S). As COPD progresses and culminates in
severe, prolonged disability (Fishman, 1998:684), it becomes "responsible for a significant
part of physician visits, emergency department visits, and hospitalisations" (Pauwels et al.,
2001: 1259). Hospital admission or readmission for an exacerbation of COPD often signals
the beginning of the terminal phase of the illness (Morgan, 2003:95). Not only is this bad
news for the patient but also "for the health services it is a significant component of the cost
of care for a condition that is increasingly burdensome" (Morgan, 2003:95). In 1993, the
United States estimated an annual expenditure of 23,9 billion dollars as a result of COPD,
including 14,7 billion dollars in direct expenditures for medical care services, 4,7 billion
dollars in indirect morbidity costs, and 4,5 billion dollars in indirect costs related to premature
mortality (GOLD, 2001b). "In 1996, lost work productivity, disability, and premature
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3mortality from COPD in the UK accounted for an estimated 24 million days of work lost"
(GOLD, 2001b). In developed countries the direct medical costs are substantial as a result of
the high prevalence and morbidity of COPD (GOLD, 200 1b). But "in developing countries,
the indirect cost of COPD from loss of work and productivity may be more important than the
direct costs of medical care" (GOLD, 2001b). In South Africa, pulmonary disorders are one
of the three main causes of disability and are increasing annually in terms of days off work
and monetary value of claim payouts" (Schorn, 2001:2).
The progressive airflow obstruction that occurs with COPD leads to permanent disability and
impaired mood state, especially with increasing severity of COPD (Wedzicha et al.,
1998:363). Several studies have shown that COPD leads to an impaired quality of life
(Wijkstra et al., 1994:269). Improved survival time is always an important aim of treatment
but due to the irreversible and progressive nature of COPD, it has now become a far more
important goal, for most patients, to improve their quality of life (QOL) (Curtis et aI.,
1994:162). The St George's Respiratory Questionnaire (SGRQ) is one of the most popular
measures of health-related quality of life (HRQL) (Jones et al., 1992: 1326). The SGRQ is an
accurate measure of the impact of COPD on a patient's daily life and well-being. The three
angles of the SGRQ measure the symptoms (frequency and severity), activites (activities that
cause or are limited by breathlessness) and impacts (social functioning, psychological
disturbances resulting from COPD) (American Thoracic Society (ATS), 2002b:no page
number).
Functional exercise intolerance is a common manifestation of patients with COPD (Maltais et
al., 1996:288), mainly due to breathlessness on exertion (Strijbos et al., 1996:366).
"Breathlessness" or "shortness of breath", referred to as dyspnea in COPD, is experienced as
a discomfort during breathing at a level of activity that is not expected. As a result of
dyspnea, COPD patients develop a lack of confidence regarding their ability to avoid
breathlessness while engaging in activities of daily living, even though they are physically
capable of performing them (Scherer & Schneider, 1997:16). "Patients with respiratory
disorders volitionally stop exercise when they are no longer willing to tolerate the intensity of
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4the accompanying symptoms" (Hamilton et al., 1995:2021). As COPD progresses, the patient
adopts a breathing pattern (usually fast and shallow) that is detrimental to gas exchange,
which may in tum worsen their symptoms (Celli, 1995:861). The progressive deconditioning
associated with inactivity initiates a vicious cycle with increased dyspnea at lower activity
demands.
"Current therapies are not very effective, and no current treatment prevents the relentless
progression of airflow limitation that characterizes this disease" (Barnes, 2003:87). "Medical
treatment has only partial success in alleviating symptoms and improving functional capacity
(Calverley and Pride, 1995:528). Pulmonary rehabilitation, as an addition to medical therapy,
has had tremendous success in enhancing the health of COPD patients beyond medication
alone. Although pulmonary rehabilitation does not improve lung function (A Statement of the
ATS and European Respiratory Society, 1999:S2), it has demonstrated many other positive
outcomes. Pulmonary rehabilitation improves QOL in COPD patients by minimising their
symptoms and improving their ability to function in activities of daily living (ADL) (Curtis et
al., 1994: 162; Celli, 1995: 864; American Association of Cardiovascular and Pulmonary
Rehabilitation (ACVPR), 1998:3; Fishman, 1998:714). Pulmonary rehabilitation reduces
hospitalisations and use of medical resources (ACVPR, 1998: 3). Studies suggest that
pulmonary rehabilitation can reduce hospital days in patients by 38% in the year following
pulmonary rehabilitation (Celli, 1995:861; Fishman, 1998:715). Reduced respiratory
symptoms (dyspnea) are experienced after pulmonary rehabilitation (Celli, 1995: 864;
ACVPR, 1998: 3; Fishman, 1998:714). COPD patients experience improved psychosocial
symptoms, for example a reversal of anxiety and depression and improved self-efficacy, after
participation in pulmonary rehabilitation (Celli, 1995: 864; ACVPR, 1998:3; Fishman,
1998:714). Pulmonary rehabilitation increases exercise tolerance and performance amongst
COPD patients (Celli, 1995: 864; ACVPR, 1998:3; Fishman, 1998:714; A Statement of the
ATS and European Respiratory Society, 1999:S2). Increased survival time is experienced in
some patients and some patients are even able to return to work (ACVPR, 1998:3; Fishman,
1998:714).
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5Pulmonary rehabilitation, a well-researched topic in westernized countries, has repeatedly
been successful. However, there has been no research published in reviewed journals with
regards to pulmonary rehabilitation in South Africa and/or other developing countries. It is
reported that the prevalence of COPD is set to increase substantially with the export of
tobacco to developing countries such as India, Mexico, Cuba, Egypt, South Africa and China
(Lomas, 2002:735). These populations are subject to a number of other risk factors that are
likely to increase their chances of developing COPD, for example the high correlation
between socioeconomic class and COPD (ATS, 1995:S79; Pauwels et al., 2001:1260; Viegi
et al., 2001:4); crowding; poor nutrition and other factors relating to lower socioeconomic
populations (Pauwels et al., 2001: 1260). It has also been found that poorer people tend to
smoke more than affluent people (WHO, 1999:68). The general population of developing
countries is not likely to have extensive medical insurance and thus they are less likely to
receive the complete medical attention that is often needed; this is reflected in the higher
morbidity and mortality rates of lower socioeconomic classes (ATS, 1995:S79; Pauwels et al.,
2001: 1260). Pulmonary rehabilitation has proved to reduce health care expenses with a
"reduction in the utilization of other health care resources such as visits to the emergency
department or a physicians office and phone calls to the physicians office" (ATS, 1999: 1669)
as well as reduced time spent in hospital (Morgan, 2003:96). If pulmonary rehabilitation is
successful in South Africa it has the potential to decrease the ill afforded medical burden that
COPD has on a developing country of many low-income groups.
Pulmonary rehabilitation is a broad term that incorporates many components. Exercise,
however, is the single most important component of pulmonary rehabilitation (Celli, 2003).
COPD patients who adhere to prescribed exercise programmes are likely to become more
actively involved in their own healthcare, more independent in performing daily activities,
and less dependent on others, including health professionals (Ries et aI., 1995:823). Exercise
training as a part of pulmonary rehabilitation has been well documented however. On review
of the literature, it appears that there is not complete consensus on the type, the intensity or
duration of exercises in order to achieve optimal benefits. According to Maltais et al.,
(1997:555) there is still no consensus about the optimal training strategy and the mechanisms
of improvement. A review of randomised trials by the ACCP/AACVPR Pulmonary
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6Rehabilitation Guidelines Panel (1997:1368) also failed to "yield firm recommendations on
optimal specific training regimens for patients with COPD". Although the principles of
training for healthy persons or for cardiac patients have been well studied, these principles do
not necessarily apply to patients with COPD (Hodgkin, Connors & Bell, 1993:90). Maltais et
al., (1997:556) suggest that "precise quantification of the amount of training actually
performed would be extremely useful in comparing results from different studies, and would
facilitate the definition of optimal training intensity and duration for COPD patients".
This study therefore aimed to quantify the precise intensity, type and duration of exercise that
accomplishes significant improvements in HRQL and functional capacity. The aim of the
study was to achieve this within a South African context and pave the way for future studies
to improve the availability of successful, cost reducing, health care resources within a country
where no such research study has been published.
PURPOSE OF THE STUDY
The purpose of this study was to determine whether participation in a 12-week exercise
programme had an effect on the health-related quality of life (HRQL), functional status,
forced expiratory lung function, dyspnea index and body mass index (BMI) of an identified
population of COPD patients.
OBJECTIVES
Primary Objectives
To investigate whether exercise has a significant effect on the following variables after a 12-
week intervention programme:
• Six-Minute Walk Test for distance (6MWT)
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7• St George's Respiratory Questionnaire (SGRQ)
• Baseline Dyspnea Index (BOl) and Transitional Dyspnea Index (TDI)
• Patient global evaluation
• Physician global evaluation
OUTLINE OF THE THESIS
Chapter two is a review of the literature regarding COPD and pulmonary rehabilitation in the
form of exercise. The second chapter also explains how exercise potentially benefits patients
with COPO. The research design and methodology are covered in chapter three with details
of all the variables used, pre- and post-intervention evaluations and the selection of patients.
Chapter four displays the data captured in the form of graphs and it explains the results that
were gathered. Chapter five concludes the thesis with suggestions of possible improvements
to the study design as well as future scope for such research.
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8CHAPTER TWO: LITERATURE REVIEW
DEFINITIONS
Chronic Obstructive Pulmonary Disease
"COPD is a disease state that is characterized by airflow limitation that is not fully reversible.
The airflow limitation is usually both progressive and associated with an abnormal
inflammatory response ofthe lungs to noxious gases" (Pauwels et al., 2001: 1256).
Emphysema
The American Thoracic Society (1995:S78) defines emphysema as:
"An abnormal permanent enlargement of the airspaces distal to the terminal
bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
Destruction is defined as lack of uniformity in the pattern of respiratory airspace
enlargement; the orderly appearance of the acinus and its components is disturbed
and may be lost."
Chronic Bronchitis
The presence of a chronic productive cough for three months in each of two successive years
in a patient in whom other causes of cough have been excluded (ATS, 1995:S78).
mSTORICAL PREVIEW
"The occurrence of diseases characterized by cough, expectoration, wheezing, and dyspnea,
first on exercise, and later at rest has been known at least since the time of Hippocrates"
(Calverley and Pride, 1995:3). According to Calverley and Pride (1995:3) Floyer gave the
first clear description of asthma in the early 18th century. Throughout the 19th century the
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9word 'asthma' was used synonymously with dyspnea. In the eighteen hundreds Laenic began
attempts to classify patients with obstructive airway diseases. "Laenic used the term
pulmonary or bronchial catarrh from the Greek word meaning 'to flow down' for excessive
production of bronchopulmonary secretion" (Calverley and Pride, 1995:3). Laenic defined
emphysema as we know it today and in 1808 Charles Badham introduced the term bronchitis
into medicine.
During the mid-20th century many studies were undertaken to determine the nature, frequency
and causes of COPD (Calverley and Pride, 1995:3). In 1958 a Ciba Foundation Guest
Symposium was held and subsequently the first attempt to achieve consensus on the
definitions of disorders associated with COPD was published (Calverley and Pride, 1995:10).
Senior and Anthonisen (1998:S 139) suggest that it was only in the 1960s that plausible ideas
about the pathogenesis of COPD appeared, when researchers in Sweden and the United States
made discoveries that have become the "cornerstone of current thinking. One was
discovering [alpha-antitrypsin] deficiency and its association with emphysema. The other
was the finding that lesions resembling human emphysema could be induced with proteolytic
enzymes in experimental animals". In 1962 the ATS gave similar descriptions of COPD to
those of the Ciba Symposium. In a historical review of COPD by Bone et al. (1997 :G3-1),
the ATS described COPD as a "disease of chronic diffuse irreversible airflow obstruction"
(Bone et al., 1997:G3-1). Subcategories included chronic bronchitis, emphysema and asthma.
These three were included as subcategories of COPD because they were "defined
pathophysiologically and the clinical and physiologic manifestations of these three diseases
overlapped" (Bone et al., 1997:G3-1). According to the ATS (1995:S78) it has since become
more practical to separate COPD from asthma. COPD and asthma have different causes,
clinical courses, and responses to therapy (ATS, 1995:S78). In 1987 the ATS made an
official statement distinguishing COPD from asthma (Bone et al., 1997:G3-1). In Bone et al.,
(1997:G3-1) the ATS defined COPD as "a disorder characterized by abnormal tests of
expiratory flow over periods of several months of observation". The three subcategories of
COPD were defined as chronic bronchitis, emphysema and peripheral airway disease (Bone et
al., 1997:G3-1).
Stellenbosch University http://scholar.sun.ac.za
10
PATHOLOGY OF COPD
COPD is characterised by progressive airflow limitation (Albert, Spiro & Jett, 1999:7.37.1)
that is not fully reversible (Barnes, 2000:269). "COPD encompasses disease conditions that
vary from chronic bronchitis, with obstruction of the airways, to emphysema, characterised by
enlargement of air spaces; destruction of lung parenchyma; loss of lung elasticity; and closure
of the airways"" (Wouters, 2002:1067).
Most COPD patients have both pathologic conditions (chronic obstructive bronchitis and
emphysema) but the extent of emphysema and chronic bronchitis in each patient varies
(Barnes, 2000:269). In the past asthma was subsumed under COPD but more recently these
conditions have been separated (ATS, 1995: S78). The airway obstruction in many patients
with COPD may include significant reversible components and some patients with asthma
may go on to develop irreversible airflow obstruction indistinguishable from COPD (ATS,
I995:S78) - particularly if they are smokers. Figure 2.1 (PIl) illustrates the relationship
between chronic bronchitis, emphysema, asthma, and airflow obstruction.
The Venn diagram below (Figure 2.1) illustrates non-proportionally the subsets of patients
with chronic bronchitis, emphysema and asthma. The shaded subsets three, four, five, six,
seven and eight are those of COPD. Asthma is defined by a reversible airflow obstruction.
Subset nine shows patients with asthma whose airflow is completely reversible. In some
cases of asthma the airflow obstruction is not entirely reversible and it becomes impossible to
differentiate patients with asthma from patients with emphysema or chronic bronchitis who
have partially reversible airflow obstruction with airway hyperreactivity. Patients with
irreversible asthma are classified as COPD, these are shown as subsets six, seven and eight.
Chronic bronchitis and emphysema with airflow obstruction usually occur together (shown in
subset five) while the patients of subset eight may have asthma associated with both chronic
bronchitis and emphysema. An asthmatic patient who is exposed to chronic irritation of the
airways, from cigarette smoke, for example, may develop a chronic productive cough - a
symptom of chronic bronchitis (subset six). Patients who have chronic bronchitis and/or
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emphysema without airflow obstruction are not classified as having COPD, as in subsets one,
two and Il. Subset lOis the group of patients with airway obstruction due to diseases such as
cystic fibrosis or obliterative bronchiolitis (ATS, 1995:S78).
Chronic
Bronchitis
Emphysema
COPD
I
l+-
I
I
I
I
Airflow
Obstruction10
Asthma
Figure 2.1. A Venn Diagram of Chronic Obstructive Pulmonary Disease (ATS, 1995:S78).
Chronic Bronchitis
Chronic bronchitis is the presence of a productive cough of more than three months for more
than two successive years (Barnes, 2000:269). Chronic bronchitis is generally characterized
by a chronic cough with excessive production of sputum (American College of Sports
Medicine (ACSM), 1998:315). A number of morphologic changes in the airways occur with
chronic bronchitis. According to Barnes (2000:269) the cough is due to:
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"hypersecretion of mucus and is not necessarily accompanied by airflow limitation.
However, there is some epidemiologic evidence that mucus hypersecretion is
accompanied by airflow obstruction, perhaps as a result of obstruction of peripheral
airways."
The chronic hypersecretion of mucus results from an increase in the number and size of goblet
cells in the bronchi and bronchioles as well as the enlargement of submucosal glands in the
proximal airways (McAllister, 2002a:41). "The submucosal glands reveal dilated ducts ... and
hyperplasia of their glandular elements" (Murray et al., 2000b: 1203). The marked increase in
submucosal glands is largely as a consequence of cigarette smoking as well as other irritants
that may be involved (Calverly and Pride, 1995:13). Submucosal gland enlargement is non-
specific to chronic bronchitis, similar changes also occur in other diseases, such as cystic
fibrosis (ATS, 1995:S81).
"Membranous airways of less than 2 mm in diameter, the [terminal] bronchioles [and alveolar
ducts], show varying degrees of plugging with mucus, goblet cell metaplasia, inflammation,
increased smooth muscle, and distortion due to fibrosis and loss of alveolar attachments"
(Murray et al., 2000b: 1203). Focal squamous metaplasia and hypertrophy of airway smooth
muscle may be present. Squamous metaplasia is mostly induced by smoking.
Chronic bronchitis is known for the development of bronchoscopically visible diverticula in
the airways and the colonization of normally sterile airways with bacteria, often Streptococcus
pneumoniae and Haemophilus injluenzae (George et al., 1990: 174).
Emphysema
Emphysema is technically a disease of the lung parenchyma secondarily affecting small
airways (ACSM, 1998:317). "The pathology includes abnormal permanent enlargement of
airspaces accompanied by destruction of alveolar walls. The biochemical basis of the disease
is an imbalance in the protease versus anti-protease equilibrium" (ACSM, 1998:317; Senior
and Anthonisen, 1998:S 139). The "protease-antiprotease hypothesis has prevailed as a central
theme for nearly 40 years" (Hogg and Senior, 2002:832). The hypothesis states that alveolar
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destruction in emphysema occurs when ''the balance between lung matrix breakdown and
defenses against lung breakdown is tipped in favor of destruction" (Hogg and Senior,
2002:832). "Proteases promote degradation of elastin and anti-proteases inhibit degradation"
(ACSM, 1998:317), the major threat being neutrophil derived elastase (a normal component
of neutrophil granules) (George et al., 1990:177). Elastin forms a large component of
connective tissue in the alveolar wall. Destruction of this lung tissue results either from
increased protease activity or a deficiency of anti-protease activity (ACSM, 1998:317).
"Smokers demonstrate significantly increased pulmonary proteolytic activities, possibly
related to accumulation of inflammatory cells (neutrophils, macrophages) containing high
concentrates of protease enzymes" (ACSM, 1995:317). Smoking is by far the most important
risk factor of COPD although of comparable importance is alphar-antitrypsin deficiency
(Albert et al., 1999:7.37.2) - a potent anti-protease (ACSM, 1998:317). Those with a genetic
alphar-antitrypsin deficiency are prone to develop severe emphysema at a young age even in
the absence of a smoking history (ACSM, 1998:317).
"The hallmark of emphysema is a loss of lung elasticity and reduction of elastic recoil
pressure due to accelerated alveolar destruction. Small airways lose radial traction to
the surrounding alveolar walls and become easily collapsible during exhalation
because intra-thoracic pressure becomes more positive. Patients with emphysema can
expel a larger volume during a slow exhalation than during a maximal force exhalation
because intra-thoracic pressure is less positive and airway compression is minimized
during a slow exhalation." (ACSM, 1998:317)
The distribution of airflow limitation is not uniform so the distribution of ventilation is
heterogenous and similarly the distribution of perfusion as the "emphysematous destruction of
the terminal lung units includes destruction of the corresponding alveolar capillaries" (Albert
et al., 1999:7.37.3). Some ventilation reaches lung units containing no capillaries and dead
space is increased (ACSM, 1998:317). Emphsematous lungs often develop bullae. Bullae are
the emphysematous spaces with a diameter of more than one centimetre in the fully distended
state (Aubry, Wright & Myers, 2000: 11). "This physiological pattern is distinct from that
seen in chronic bronchitis" (ACSM, 1998:317).
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Three types of emphysema can be distinguished. The first type, centriaeinar or centrilobular
emphysema, begins in the respiratory bronchioles and spreads peripherally (ATS, 1995:S81).
"Fenestrations develop in the airway walls, enlarge, become confluent, and form a single
space as the walls disintegrate. Initially, the most distal alveolar ducts and sacs and the
alveoli are preserved" (Bone et al., 1997:G3-4). Centriaeinar emphysema can cause bullous
emphysema when numerous spaces enlarge to a diameter of more than one centimetre (Aubry
et aI., 2000:13). Centrilobular emphysema is a form of emphysema associated with
longstanding cigarette smoking (ATS, 1995:S81). Centrilobular emphysema predominantly
involves the upper half of the lungs and is prevalent in males (Bone et al., 1997:G3-4). Focal
emphysema is the form of centriaeinar emphysema that occurs in coal worker's
pneumoconiosis (ATS, 1995:S81).
The second type is panacinar emphysema. Panacinar emphysema "involves the entire acinis,
progressing from early diffuse destruction, in which the distinction between alveolar ducts
and alveoli is lost, to total effacement of the alveolus, with only strands of lung tissue
remaining" (George et al., 1990:176), which are usually blood vessels (Bone et al., 1997:G3-
4). Panalobular emphysema is characteristically uniformly distributed throughout the lung,
although the basal areas of the lung tend to be most affected (Bone et al., 1997:G3-4). Focal
panacmar emphysema at the lung bases may accompany centrilobular emphysema in
smokers.
The third type, distal acinar emphysema, also known as paraseptal emphysema, preferentially
involves distal airway structures, alveolar ducts, and sacs (ATS, 1995:S81). This form of
emphysema is thought to be a major cause of spontaneous pneumothorax (Bone et al.,
1997:G3-4). With this form of emphysema, airflow is frequently well preserved (ATS,
1995:S81). A large amount of overlap exists between the three types of emphysema to the
extent that the clinical diagnoses of pure centrilobular or panacinar emphysema requires the
use of expensive technology (i.e. computed tomography).
Stellenbosch University http://scholar.sun.ac.za
15
PATHOPHYSIOLOGY OF COPD
Pathological changes in the lungs lead to physiological changes characteristic of COPD
(Pauwels et aI., 2001: 1258-1259; GOLD, 2001b). Pathological changes include and usually
occur in this order over the course of the disease: mucus hypersecretion, ciliary dysfunction,
airflow limitation, pulmonary hyperinflation, gas exchange abnormalities, pulmonary
hypertension and cor pulmonale (Pauwels et aI., 2001: 1258-1259; GOLD, 2001b). Mucus
hypersecretion and ciliary dysfunction cause a chronic cough and the production of sputum,
these two symptoms are often present for many years before the development of other
symptoms or physiologic abnormalities occur (Pauwels et aI., 2001: 1258-1259; GOLD,
2001b).
"Expiratory airflow limitation, best measured through spirometry, is the hallmark physiologic
change of COPD and the key to the diagnoses of the disease" (Pauwels et aI., 2001: 1258-
1259; GOLD, 2001b). This is largely as a result of airway obstruction and the consequent
increase in airway resistance and to a lesser extent the destruction of alveolar attachments,
which inhibits the ability of the small airways to maintain patency (Pauwels et aI., 2001:
1258-1259; GOLD, 2001b).
In the advanced stages of COPD, peripheral airways obstruction and parenchymal vascular
abnormalities reduce the lung's capacity for gas exchange resulting in hypoxemia and, later
on, hypercapnia (Pauwels et aI., 2001: 1258-1259; GOLD, 2001b). Pulmonary hypertension
is a frequent and major cardiovascular complication which develops late in the natural history
of COPD (Stage III: Severe COPD) (Pauwels et al., 2001: 1258-1259; GOLD, 2001b).
Pulmonary hypertension is associated with the development of cor pulmonale, shorter
survival rates and frequent use of health resources (Barbera, Peinado & Santos, 2003:892).
Figure 2.2 illustrates the pathophysiology of COPD and cor pulmonale in COPD (adapted
from Pierson, 2000:47; Pauwels et al., 2001: 1259).
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Figure 2.2. Pathophysiology of COPD and cor pulmonale in COPD (adapted from Pierson,
2000:47; Pauwels et al., 2001: 1259).
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RISK FACTORS FOR COPD
The following are risk factors for COPD: smoking habit; passive smoking; ambient air
pollution; alpha.-antitrypsin deficiency; airway and allergy hyperresponsiveness; childhood
infections; low birth weight; gender; race; socioeconomic status; tuberculosis (TB); and
occupational factors (ATS, 1995:S79; Fishman, 1998:662). The primary risk factor of COPD
is unquestionably tobacco smoking (ATS, 1995:S79; Senior and Anthonisen, 1998:141), with
alpha.-antitrypsin (a genetic factor) being the second most important risk (Fishman,
1998:662). The most common risk factors are elaborated in more detail.
Smoking Habit
"Since about 1950, more than 70 000 scientific articles have left no scientific doubt
that prolonged smoking is an important cause of premature mortality and disability
worldwide. Estimates suggest that in developed countries, smoking will have caused
about 62 million deaths between 1950 and 2000. The WHO now estimates that
smoking causes about four million deaths annually worldwide." (WHO, 1999)
A study by Lundback et al., (2003:118) found that as many as 50% of smokers may develop
COPD, not the 10-15% proposed in past literature (Scanlon et al., 2000:382; Barnes,
2003:88). COPD patients who smoke have a higher mortality rate, they also have a higher
prevalence of lung-function abnormalities, respiratory symptoms and all forms of COPD
(ATS, 1997:S79). "Pipe and cigar smokers have a higher morbidity and mortality rates for
COPD than nonsmokers, although their rates are lower than those for cigarette smokers"
(ATS, 1995:S79). The Lung Health Study by Senior and Anthonisen (1998:S141) found that
airways reactivity was greater in women than in men smokers, and forced expiratory volume
(FEVl) may decline more rapidly in women when allowances are made for lung size and
degree of smoking. Lomas (2002:735) also states that COPD is becoming more prevalent
among "western women and is set to increase substantially with the export of tobacco to
developing countries such as India, Mexico, Cuba, Egypt, South Africa and China".
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Fletcher and colleagues (1976) concluded in their study that tobacco smoke is the direct cause
of lung damage of COPD. Not all smokers develop clinically significant COPD, suggesting
that genetic factors modify each person's risk (Pauwels et al., 2001:1260) although the
genetic contribution to COPD is poorly understood (Scanlon et al., 2000:382). The ATS
(1997:S79) states that mortality in COPD patients can be predicted by the age the patient
started smoking, total pack years (pack years are the number of years the patient has smoked,
multiplied by the number of cigarettes smoked per day divided by 20] and current smoking
status. Factors that contribute to the development of COPD include heavy tobacco smoking,
long duration of smoking and smoking of high tar cigarettes (Scanlon et al., 2000:382). On
average, a cigarette smoker's rate of expiratory airflow decreases twice as fast (40 ml a year)
compared to that of non-smokers (20 ml a year) (Fishman, 1998: 699). However, to a certain
extent, the cessation of smoking can halt the progression of COPD (Wise, 1997:418).
According to Hodgkin et al., (1993: 120), "if cigarette abstinence occurs early enough, COPD
patients with mild dysfunction may delay or perhaps eliminate their predicted encounter with
severe pulmonary impairment". Baum and Wolinsky (1994:1004) go so far to say that if
cigarette smoking were to cease, COPD would disappear as an important health problem.
"Hence, the most direct approach to reduce the risk of COPD is to reduce cigarette smoking"
(Scanlon et al., 2000:382). Figure 2.3 is a graph that shows the decline in lung function of
smokers, non-smokers and smokers who quit smoking (Davies, n.d.).
A number of interacting mechanisms appear to be operating in the pathogenesis of COPD
caused by cigarette smoking. According to Fishman (1998:699), emphysema develops from
lung damage, "which can be caused by either direct injury inflicted by cigarette smoke -
reduced oxidants or by inflammatory mediators recruited into the lung as a consequence of
exposure to smoke". Chronic bronchitis appears to develop from similar mechanisms in the
airways (Fishman, 1998:699).
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Figure 2.3 Graph of Survival (Davies, n.d.)
"Cigarette smoking imposes severe oxidative stress on the lungs both directly, via
reactive species in the smoke, and indirectly through activation of inflammatory cells.
Oxidative stress may contribute to COPD through many biological actions, including
cellular injury, oxidation and nitration of proteins, changes in gene expression,
stimulation of mucous secretion, inactivation of antiproteases, expression of
proinflammatory mediators, remodeling of blood vessels, and enhancement of
apoptosis. Markers of oxidative stress (e.g., hydrogen peroxide, 8-isoprostane, and
lipid peroxides) are elevated in the breath or serum of subjects with COPD, and
epidemiological studies have demonstrated negative associations of dietary antioxidant
intake with pulmonary function and with obstructive airway disease." (Croxton et al.,
2002:841)
"Passive exposure to cigarette smoke may also contribute to respiratory symptoms and COPD
by increasing the lung's total burden of inhaled particulates and gases" (Pauwels et al.,
2001 :1260). Passive smoking is also referred to as environmental tobacco smoke or "second-
hand smoke" by the ATS (l995:S79). According to the ATS (1995:S79), children whose
parents smoke have a higher prevalence of respiratory disorders and appear to have
deficiencies in tests of pulmonary function when compared to children with non-smoking
parents. Smoking during pregnancy is also thought to "pose a risk for the fetus, by affecting
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lung growth and development in utero and possible priming of the immune system" (Pauwels
et al., 2001:1260). The ATS (1995:S79) suggests that all children should be protected from
exposure to tobacco smoke.
Genetic Factors
Genetic factors are important in determining a person's predisposition to the development of
emphysema (Barnes and Godfrey, 1997:3). According to Fishman (1998:662), the strongest
genetic risk is the deficiency of alpha.-antitrypsin. Although in the United States a genetic
deficiency of alphar-antitrypsin accounts for less than 1% of COPO (ATS, 1995:S79).
Alphar-antitrypsin (also known as alphar-protease inhibitor) is a serum protein produced by
the liver and normally found in the lungs. Its main role is the inhibition of neutrophil elastase
(ATS, 1995:S79). A deficiency in alphar-antitrypsin results in the destruction of elastin by
the neutrophil elastase and a tendency to develop severe emphysema at a young age even in
the absence of a smoking history (ACSM, 1998:317). Although even with smoking and
alphar-antitrypsin deficiency (the two highest risk factors), it is still not possible to predict
who will actually develop COPD (Fishman, 1998:662).
Ambient Air Pollution
Exposure to air pollution, particularly sulphur dioxide and particulates (black smoke), is
associated with an increased prevalence of chronic bronchitis and COPD (Barnes and
Godfrey, 1997:3). A difference is noted between the death rates of urban compared to rural
dwellers with COPO (Fishman 1998: 662). However, the role of air pollution in the aetiology
of COPD is thought to be fractional compared to the role of cigarette smoking (ATS,
1995:S79; Pauwels et al., 2001 :1260). There has also been an association oflung deficiencies
with indoor nitrogen dioxide levels and damp housing (ATS, 1995 :S79). The ATS
(1995:S79) also suggests that "the use of solid fuels for cooking and heating without adequate
ventilation" may result in "high levels of indoor air pollution and account for the development
of COPO".
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Infections
"Chest infection during the first year of life is associated with COPD in later life" although
there is "little evidence that subsequent chest infections are important in this regard" (Barnes
and Godfrey, 1997:3). More recent studies concluded that bacterial colonisation is actually an
important factor relating to the decline of lung function in COPD patients, and that rising
airway bacterial load and a change in bacterial species are associated with greater airway
inflammation and accelerated decline in lung function (Wilkinson et al., 2002: I095).
According to Pauwels et al., (200 1:1260) it is a history of severe childhood respiratory
infections that is associated with "reduced lung function and increased respiratory symptoms
in adulthood". Although Pauwels et al., (200 1:1260) state that the viral infections may be
related to other factors, for example, low birth weight (also known to presage "low FEV 1 and
high COPD mortality in later life") (Fishman, 1998:662).
Tuberculosis
"Tuberculosis (TB) is a contagious, potentially fatal infection caused by the airborne
bacterium Mycobacterium tuberculosis, Mbovis, or M africanum " (Stead, 2000:no page
number). A person infected with TB has a five percent chance of developing an active
infection within one to two years (Stead, 2000:no page number). A person infected with
AIDS who becomes infected with TB has a 50% chance of developing active TB within two
months of the last infection (Stead, 2000:no page number). South Africa, in particular, "is
burdened by one of the worst tuberculosis epidemics in the world, with disease rates of more
than double those observed in other developing countries and up to 60 times higher than those
currently seen in the USA or Western Europe" (Fourie, 2003:no page number). South Africa
is also known to have extremely high rates of HIV infection and thus it can be expected that
TB in many patients is recurrent. "The residual damage to the lung tissue after completion of
tuberculosis treatment includes varying degrees of fibrosis, bronchiovascular distortion,
emphysema and bronchiecstasis" (Hnizdo, Singh & Churchyard, 2000:36). A recent study
on South African miners showed that the increasing number of episodes of TB corresponded
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with an increasing loss of lung function (Hnizdo et aI., 2000:36). Hnizdo et aI., (2000:37)
estimated that a:
"decrease in FEV I in subjects with one episode of tuberculosis was 326 ml after six
months, 247 ml after one year, and stabilised at an average residual loss of 153 ml
over the total follow up period; for subjects with two episodes of tuberculosis the
temporal loss of FEV J was 499 ml after six months, 419 ml after 12 months, and
stabilised at an average residual loss of 326 ml from 12 months onwards; while for
subjects with three episodes of tuberculosis the temporal loss of FEV I was 583 ml
after six months, 503 ml after 12 months, and stabilised at an average residual loss of
410 ml." (Hnizdo et al., 2000:37)
Hnizdo et al., (2000:37) concluded that TB can cause chronic lung function impairment (with
an increased obstructive pattern in the airways with increasing duration of the follow up
period) which increases incrementally with the number of episodes of TB, affecting
approximately 18% of subjects with one episode, 27% of subjects with two episodes, and
35% of subjects with three episodes of TB. Therefore, the large population of South Africans
who suffer from TB, especially recurrent TB, are at high risk of developing COPD.
Gender, Race and Soclo-economic Status
After standardization for smoking, males are more at risk than females for the development of
COPD (ATS, 1995:S79; Fishman, 1998:662). Mortality rates are higher amongst whites than
other races, although the difference is decreasing in males (ATS, 1995:S79). There is
evidence that morbidity and mortality rates in COPD are inversely related to socio-economic
status and are higher in blue-collar than white-collar workers (ATS, 1995:S79; Pauwels et al.,
2001:1260). Although according to Pauwels et aI., (2001:1260) it is not completely clear
"whether this pattern reflects exposures to indoor and outdoor air pollutants, crowding, poor
nutrition, or other factors that are related to socioeconomic status".
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Occupational Factors
Occupational factors are associated with increased prevalence of COPD, increased FEV I
decline, and a higher mortality rate (ATS, 1995:S79). When the exposures to occupational
dusts and chemicals (vapours, irritants or fumes) are prolonged or intense, the risk of COPD
may be increased in the presence of concurrent cigarette smoking (Pauwels et al., 2001: 1260).
"Many dusts cause mucus hypersecretion; persistent obstruction develops in coal and gold
miners, farmers, grain handlers and cement and cotton workers" (Fishman, 1998:662).
Cadmium workers have increased risk of emphysema (Barnes and Godfrey, 1997:3; Fishman,
1998:662). "Exposure to particulate matter, irritants, organic dusts, and sensitising agents can
cause an increase in airway hyperresponsiveness, especially in airways already damaged by
other occupational exposures, cigarette smoke, or asthma" (Pauwels et al., 2001 :1260).
CLINICAL FEATURES OF COPD
Patient History
COPD patients usually present in the fifth decade of life with a cough productive of sputum
(Albert et al., 1999:7.37.6), which manifests after an acute chest illness, and in the sixth or
seventh decade of life COPD patients experience dyspnea on exertion (ATS, 1995:S81). "The
typical patient who develops COPD has smoked more than 20 pack years before symptoms
develop" (Albert et al., 1999:7.37.6). Primary symptoms may include a history of "chronic,
productive cough, episodic wheezing, and various degrees of shortness of breath increasingly
associated with exertion, e.g., climbing stairs and carrying packages" (Mahler, 1990:12).
Later in the course of the COPD an exacerbation may give rise to hypoxemia with cyanosis,
the latter being exacerbated by erythrocytosis (ATS, 1995:S81). The sputum of a patient
experiencing an exacerbation will generally increase in volume and become purulent (Albert
et al., 1999:7.37.6). "These episodes of acute bronchitis are usually accompanied by
increased dyspnea, bronchospasm, and low-grade fever. As the disease progresses, the
intervals between exacerbations shorten." (Albert et al., 1999:7.37.6)
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Morning headaches suggest the presence of hypercapnia (Albert et al., 1999:7.37.6). Weight
loss occurs in some patients, and cor pulmonale with right ventricular failure and oedema may
develop in those who have abnormal oxygenation (Albert et al., 1999:7.37.6). "Bronchogenic
carcinoma occurs with increased frequency in smokers with COPD" thus an episode of
hemoptysis raises the possibility that a carcinoma has developed (ATS, 1995:S81).
Physical Examination
Visual examination of the patient may be unremarkable in the early stages of stable chronic
obstructive pulmonary disease (George et al., 1990:178). Calverley and Pride (1995 :313)
suggest that careful inspection rather than palpation or auscultation reveals the most useful
physical signs of COPD. "It is important to observe the breathing pattern. Symptomatic
patients will often have a prolonged expiratory phase and some will purse their lips in
expiration. Patients adopting pursed lip breathing at rest usually have a severely reduced
FEV1 and hyperinflation" (Calverley and Pride, 1995:313). Forced contractions of the
abdominal muscles can be seen throughout expiration, this increases at end exhalation (Albert
et al., 1999:7.37.7). Paradoxical indrawing of the lower chest wall, known as Hoover's sign,
is often evident (ATS, 1995:S81). "The patient at end-stage COPD may adopt postures that
relieve and/or facilitate the function of accessory respiratory muscles (i.e. leaning forward
while standing or sitting with the arms positioned on the knees or table), thereby reducing
dyspnea" (Albert et al., 1999:7.37.7). When the patient leans forward and supports
himlherself the shoulder girdle becomes fixed and allows the muscles such as the pectorals
and latissimus dorsi to be used for increased rib cage movement (Calverley and Pride,
1995:313). George et al., (1990: 178) name this the ''tripod sign". Mahler (1990: 12) also
reports on the appearance of a barrel-shaped chest amongst dyspneic patients.
Examination of the chest may reveal decreased breathing sounds, prolonged expiration and
distant heart sounds (ATS, 1995:S81). "Coarse crackles may be heard at the lung bases.
Wheezes are frequently heard, especially on forced expiration" (ATS, 1995:S81). As the
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airflow obstruction progresses, however, hyperinflation of the chest becomes evident as the
anteroposterior diameter of the chest increases (Albert et al., 1999:7.37.7). The diaphragm
flattens and becomes limited in its caudal motion (Albert et al., 1999:7.37.7). Hyperinflation
of the lungs is confirmed with a positive Hoover's sign.
COPD patients are divided into two extreme groups, the "pink puffers" and the "blue
bloaters". "Pink puffers" are those who are dyspneic from vigorous breathing but maintain
their arterial P02 and PC02 in an almost normal range (Murray et al., 2000b: 1634). The
"pink puffer" usually presents with a slight body build, a tendency to lean forward over a
support to assist breathing and the use of pursed-lip expiration (Barnes and Godfrey,
1997: 11). The "pink puffer" has an overinflated chest, confirmed with radiographic images,
with quiet breathing sounds and no adventitious sounds (West, 1995:57). The "pink puffer"
usually represents with predominantly panacinar emphysema. The "blue bloaters" are those
COPD patients who become cyanotic and oedematous because of hypoventilation with
consequent hypoxia and hypercapnia (Murray et al., 2000b: 1634). The "blue bloater' is
described as stocky and sometimes overweight (Baum and Wolinsky, 1994:987) with
pronounced cyanosis at rest and mild exertion (Barnes and Godfrey, 1997: 11). These patients
also present with crackles at lung bases, a loud second heart sound in the pulmonary area as
well as oedema of the ankles (Barnes and Godfrey, 1997:11). The "blue bloater" usually
represents with predominantly centrilobular emphysema.
Signs of cor pulmonale may include jugular distension, an enlarged tender liver, patients may
have right upper-quadrant tenderness and bilateral pedal oedema occurs (Albert et aI.,
1999:7.37.7). "Kussmaul's sign (i.e. decreasing jugular venous pressures during inhalation)
may be observed in the absence of heart failure, as a result of the compressive effect of lung
inflation on cardiac filling" (Albert et aI., 1999:7.37.7). According to George et al.,
(1990: 179) the Doppler flow echocardiography is a sensitive technique for detecting cor
pulmonale.
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LABORA TORY FINDINGS AND DIAGNOSTIC TESTS
Pulmonary Function Measurements
"Pulmonary function measurements serve to assess the severity of airflow limitation, to
quantify the presence of the various abnormalities, and to identify and quantify reversible
airflow limitation" (Murray et al., 2000b: 1190). Pulmonary function tests also help to
determine the progress of the disease (ATS, 1997:S82).
Forced Expiratory Spirometry
"The forced expiratory spirogram is the most useful test of airflow dynamics" (Murray et al.,
2000b: 1191). The spirogram is recorded as either a flow-volume or a volume-time plot
(Barnes and Godfrey, 1997:14). It measures the maximal volume of air forcibly exhaled from
the point of maximal inhalation (FVC) (Pauwels et al., 2001b:1261); the volume of air
expired in the first second (FEVI); the middle half of the FVC (FEV2s.7s); and the peak
expiratory flow (PEF) (Murray et al., 2000b:1261). The FEV1, FVC, FEV1/FVC ratio and the
FEV2s.7s are all reduced as COPD progresses (West, 1982:71). The FEV1 has little variation
and is more accurately predictable from age, sex and height than the FEV2s-7s (Murray et al.,
2000b: 1191). The reduced ratio of FEV IIFVC is associated with obstructive diseases but is
preserved in restrictive pulmonary disorders (Baum and Wolinsky, 1994: 1002), making it an
important measure to differentiate between the two disorders. FEV I is used in the diagnosis
of COPO and in the determination of disease severity. "FEV1 has been shown to correlate
with death and disability in COPD and is considered an important staging criterion" (Berry et
al., 1999: 1248). Table 2.1 illustrates the use of FEV1 and FVC in COPO disease staging
(Pauwels et al., 2001: 1257). PEF is an estimate of the function of the larger airways and is
very effort dependent (Barnes and Godfrey, 1997:14). "PEF is not as useful in COPO as in
asthma, as it may be relatively well preserved in emphysema" (Barnes and Godfrey, 1997: 14).
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Table 2. J GOLD Staging Criteria of COPD (Pauwels et al., 2001: 1257)
Stage Characteristics
0: At Risk Normal spirometry
Chronic symptoms (cough, sputum production)
I: Mild COPD FEV]IFVC < 70%
FEV] :::80% predicted
With or without symptoms (cough, sputum production)
II: Moderate COPD FEV]IFVC < 70%
30%:s FEV] < 80% predicted
(IIA: 50% :s FEV] <80% predicted)
(lIB: 30%:s FEV] < 50% predicted)
With or without symptoms (cough, sputum production, dyspnea)
III: Severe COPD FEV]IFVC < 70%
FEV] < 30% predicted, or the presence of respiratory failure, or
clinical signs of right heart failure
The bronchodilator reversibility test is often performed at the time of diagnoses. A high dose
(four puffs) of a beta agonist is given to the patient and spirometry is performed after 15
minutes (McAllister, 2002b:28). This test helps to eliminate the diagnoses of asthma, "to
establish the patient's best attainable lung function, to gauge a patient's prognosis, and to
guide treatment decisions" (Pauwels et al., 2001: 1261). "An increase in FEV] of 200ml and
15% demonstrates reversibility above that expected by chance, while an increase of 400ml or
more suggest a significant asthma element" (McAllister, 2002b:28). Failure to reverse to
normal or by more than 400ml, demonstrates irreversible airflow obstruction (McAllister,
2002b:28). Duek (2000:426) in the Journal of Clinical Monitoring and Computing
recommends that the differentiation of asthma and COPD be based primarily on patient
history of intermittent wheezing, reactivity to allergens and airway irritants as well as the
bronchodilator reversibility test. Duek (2000:426) uses the reference value of at least 200 ml
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or more than 12% increase in FEVl after the administration of a bronchodilator (clinicians
generally apply a combination of the two reference values).
The expiratory flow-volume curve or loop is produced by most modern spirometers. The
appearance of the flow-volume curve is highly characteristic in COPD (see Figure 2.4). The
information from the flow-volume loop is also obtained as absolute values from the
spirometer. An accurate diagnosis of COPD combines the spirometric readings with the
patient's medical history.
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Figure 2.4. Flow volume loops showing normal (left) and severe airflow obstruction (right)
Lung Volumes
Spirometry alone is usually sufficient when evaluating the abnormalities of lung mechanics in
COPD. However, lung volume measurement becomes necessary when the disease is very
severe or there is doubt about the diagnosis, or when it is important to know the extent of the
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emphysema (Barnes and Godfrey, 1997:16). Duek (2000:426) suggests the measurement of
total lung capacity (TLC) when the COPO patient's FVC is less than 80% of the predicted
value. This is to rule out superimposed restrictive pulmonary dysfunction and for assessing
the severity of hyperinflation (Duek, 2000:426). Lung volumes are preferably measured with
plethysmography but can also be measured by either the "washin or the washout of tracer
gases such as helium" (Baum and Wolinsky, 1994:999). Patients with emphysema have
typically increased TLC, functional residual capacity (FRC) and residual volume (RV) (West,
1995:60). TLC is increased due to the loss of elastic recoil that permits the inspiratory
muscles to stretch the lungs to a greater maximal volume (Murray et al., 2000b:1191). RV is
increased because of airway closure at higher lung volumes, due to a combination of loss of
elastic recoil and bronchiolitis (Murray et al., 2000b: 1191). FRC is increased because of loss
of elastic recoil (Murray et al., 2000b: 1191). Expiratory reserve volume (ERV) and
inspiratory capacity (IC) are slightly reduced in COPO (Barnes and Godfrey, 1997: 18). Slow
vital capacity (SVC) is reduced in more severe COPD and airways resistance (Raw)is usually
increased. Vital capacity (VC) is decreased due to the increase in RV (Murray et al.,
2000b:1191). Variations in the pattern of lung volumes is often seen in patients with mild to
moderate COPD, these variations tend to disappear as the disease becomes more severe
(Murray et al., 2000b: 1191).
Arterial Blood Gases
Measurement of arterial blood gases is important in advanced COPO patients (Pauwels et al.,
2001: 1261). Pauwels et al., (200 1:1261) recommend that arterial blood gas measurements
should be performed in patients with FEV 1 of less than 40% of predicted or with clinical signs
that suggest respiratory failure or right heart failure. Arterial blood gases also "reveal mild or
moderate hypoxemia without hypercapnia in the early stages of COPO" (Murray et al.,
2000b: 1192). Arterial blood is usually sampled from the radial artery or from an indwelling
radial artery catheter (West, 1995:17). Pauwels et al., (2001: 1261) find the finger or ear
oximeters for assessing Sa02 less reliable than the measurement of blood gases via an actual
blood sample. However, it is not always practical to take blood samples when needing an
immediate blood gas reading and thus the pulse oximeter becomes necessary. Therefore, in
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order to get the most accurate reading possible from a pulse oximeter, it is essential that users
of pulse oximeters are familiar with the procedure and they are aware of the many factors that
may affect measurements (Martin, 1999:96-97). Blood gas abnormalities worsen with
exacerbations and potentially during sleep and exercise (Murray et al., 2000b: 1192).
The volume-pressure relation is a measure used to measure the transpulmonary pressure at
total lung capacity (Murray et al., 2000b: 1191). It is a measure that is seldom used in clinical
practice but more as a research procedure. The single-breath diffusing capacity measures the
distribution of ventilation in the lungs (Baum and Wolinsky, 1994: 1000). Diffusion capacity
(DLco) is decreased in COPD patients as the "emphysematous lungs have lost much of their
alveolar surface and, thus, the area available for diffusion and the capillary blood volume are
reduced" (West, 1995:65). This measure is not sensitive to low grades of emphysema.
Chest Radiography
According to the ATS (1997:S82) emphysema is most clearly evident on radiographic images
of the lungs. Chronic bronchitis, however, cannot be diagnosed by chest radiographs,
although radiographic signs may suggest the diagnosis (Murray et al., 2000b: 1190).
Two patterns (that are indicative of COPD) may show on radiographic images of the lungs.
These are arterial deficiency and increased markings (Murray et al., 2000b:1190). The
pattern of arterial deficiency consists of overinflation, oligemia (deficiency in the volume of
blood), and bullae (Murray et al., 2000b: 1190). This is characteristic of emphysema.
Hyperinflation is indicated by a low and flattened diaphragm (Davies, 1981:34). (See Figure
2.5 for the typical appearances of emphysema on a chest X-ray). The lateral image may show
an increased retrosternal airspace and the heart shadow may look small as the heart is pulled
down and rotated by the hyperinflation (Davies, 1981:35). The pattern of increased markings
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is characteristic of chronic bronchitis (Murray et al., 2000b: 1190). Bullae are frequently seen
on radiographic images of emphysematous lungs, they appear as curvilinear shadows
enclosing empty airspaces (Davies, 1981: 36). Fishman (1998:633) does not advise
radiographic images as reliable indicators of impairment or disability. Fishman (1998:633)
states that there is a poor correlation between chest radiographic findings and pulmonary
function abnormalities among patients with obstructive lung disease. Murray et al.,
(2000b: 1190) agree that emphysema patients show very little evidence on chest radiograph
images until the disease is moderately advanced. According to the ATS (1997 :S82),
emphysema is consistently diagnosed when the disease is severe, but it is not diagnosed when
the disease is mild and is diagnosed in about half the cases of moderate disease. Sub-cardiac
air trapping also indicates hyperinflation. Figure 2.5 shows a typical chest X-ray of an
emphysematous lung (Mak, n.d.).
Figure 2.5. Typical chest X-ray of an emphysematous lung (Mak, n.d.)
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Computed Tomography
Computed tomography (CT) has much greater sensitivity and specificity than standard chest
radiography. High resolution CT can "diagnose emphysema accurately even before air flow
obstruction has developed" (Baum and Wolinsky, 1994:303). High resolution CT can be used
to help quantify the amount of air trapping by comparing images during inspiration and full
expiration (Murray et al., 2000b: 1190). "When regional variations in lung tissue density are
quantitated by CT scans, remarkably good correlations with the extent of anatomic
emphysema can be demonstrated" (Baum and Wolinsky, 1994:997). CT is mainly used as an
investigational tool. However, "precise knowledge concerning the anatomic distribution and
severity of emphysema only rarely has practical implications in clinical management" (Baum
and Wolinsky, 1994:997). The large expense of this imaging technique precludes its general
application for the management of COPD.
Sputum Examination
In stable chronic bronchitis, sputum is mucoid, and microscopic examination reveals a
predominance of macrophages (ATS, 1997:S82; Murray et al., 2000b:1192). During an
exacerbation the sputum is grossly purulent with an influx of neutrophils (Murray et al.,
2000b: 1192). On the Gram's stain there is an increase in the number of organisms seen
(Murray et al., 2000b: 1192). "The most frequent pathogens cultured from the sputum are
Streptococcus pneumoniae and Haemophilus influenzae. Other oropharyngeal flora, such as
Moraxella catarrhalis, have been shown to cause exacerbations" (ATS, 1997:S82). Viral
infections can also trigger an exacerbation of the disease. Outpatients seldom require a
culture or Gram's stain for institution of antimicrobial therapy (ATS, 1997:S82), unless the
patient has sustained an exacerbation during or soon after receiving a course of antibiotic
therapy (Murray et al., 2000b: 1192). Recent studies have shown that lower airway bacterial
colonisation in stable state COPD plays a role in the character and frequency of COPD
exacerbations (Patel et al., 2002:759).
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FACTORS TRAT AFFECT EXERCISE TOLERANCE
Dyspnea
Dyspnea on exertion is the most frequent complaint of COPD patients (Mahler, 1990:168).
Dyspnea is defined as "an uncomfortable awareness of breathing or an increased respiratory
effort that is unpleasant and regarded as inappropriate by the patient" (Mahler et al.,
1984:751). Celli (2003b) explains dyspnea as a feeling of running out of air and being unable
to breathe fast enough or deeply enough. "Other sensations include an awareness of increased
muscular effort to expand the chest when breathing in or to expel air when breathing out, the
uncomfortable sensation that inhaling (inspiration) is urgently needed before exhaling
(expiration) is completed, and various sensations most often occur described as tightness of
the chest." (Celli,2003b)
Dyspnea is usually first noticed when a COPD patient experiences an unusual amount of
breathlessness climbing stairs or walking uphill. According to Mahler (1990: 169) some
patients with COPD experience disabling breathlessness when performing seemingly trivial
upper extremity activities, such as combing their hair, bathing etc. The hyperventilation
experienced by most COPD patients during exercise causes hypocapnia and subsequent
symptoms of dizziness, palpitations, paresthesiae, faintness and sometimes chest pain
(Folgering & Van Herwaarden, 1994:110). Dyspnea is progressive in COPD and as a result
of the disturbing symptoms COPD patients tend to unknowingly reduce their level of
activities. The reduction of activity leads to further deconditioning and further exercise
limitation (Mahler, 1990:169). Dyspnea, however, has shown to decrease after exercise
training. The reduction of dyspnea after exercise in COPD patients has thought to be
attributed to desensitisation of COPD patients to dyspnea with reduction in fear and anxiety as
a result of repeated exercise (Carrieri-Kohlman, 1996: 1533). This is similar to methods used
to treat persons with phobias in which they are repeatedly exposed to a stimulus over time in a
safe environment which gradually lessens fear and anxiety associated with the stimulus.
However, it is questionable whether desensitisation is the true mechanism of improved
dyspnea levels. Carrieri-Kohlman et al., (1996: 1534) suggested repeated exercise facilitates
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the development of coping strategies, such as pursed-lip breathing, rather than desensitising
the patient to dyspnea. Carrieri-Kohlman et al., (1996), undertook a very important study of
the decrease of dyspnea in COPD patients after exercise training with coaching that included
instruction in coping strategies, breathing techniques, and goal setting. This group of COPD
patients was compared with a group of patients who exercised without coaching in a
monitored environment. Carrieri-Kohlman et al., (1996: 1534) concluded that coaching does
not significantly reduce dyspnea in COPD patients, "exercise alone is a powerful intervention
for increasing exercise performance and decreasing dyspnea" in a monitored laboratory, as
well as with ADL. The results of Carrieri-Kohlman et al., (1996: 1534) emphasize the
"importance of having exercise training programs available to patients with chronic lung
disease".
Malnutrition
Twenty (20) - 70% of the COPD population are underweight compared with the ideal body
weight (Engelen et al., 1994:1793). Weight loss and low body weight correlate with
increased morbidity and poor prognosis of patients with COPD (Engelen et al., 1994:1793).
"Malnutrition is common in patients with severe COPD. Patients' lung function is often so
poor that they cannot cook for themselves, and even eating a meal prepared for them can be a
huge effort" (Fehrenbach, 2002:50). COPD patients experience elevated energy metabolism,
which is not adequately met by a decreased spontaneous dietary intake (Schols, 1998:1791).
Significantly reduced body weight in advanced chronic pulmonary disease is related to
decreased exercise capacity (Shoup et al., 1997:1576). A positive relationship between
nutritional depletion and decreased peripheral and respiratory muscle strength is reported by
Engelen et al., (1994: 1796), especially of the peripheral muscle groups. Shoup et al.,
(1997:698) found a positive correlation between body weight and distance walked in the 12-
minute walk test by COPD patients.
Nutritional depletion can be measured in different ways. Engelen et al., (1994: 1796)
measured body weight as a percentage of ideal body weight adjusted for frame size and
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height. Measures of body composition have also been used to assess the percentage of lean
body mass. Such measures include the bioelectrical impedenee method and the measurement
of skinfoids. Body mass index (BMI) is a commonly used measure of nutritional depletion.
The table below shows the classification of BMI in healthy individuals (ACSM, 2000:62).
Specifically designed questionnaires have also been used to measure nutritional depletion.
Table 2.2. Classification ofBMI (ACSM, 2000: 64)
BMI, kg/mz
Underweight < 18.5
Normal 18.5 - 24.9
Overweight 25.0 -29.9
Obesity, class I 30.0 - 34.9
Obesity, class II 35.0 - 39.9
Obesity, class III ~40
For healthy individuals the lowest health-risk category is that of individuals whose BMI
ranges from 20 to 25, and the highest-risk category is that of individuals whose BMI exceeds
40. The suggested desirable BMI range for women is 21.3 to 22.1; for men, it is 21.9 to 22.4
(McArdle, Katch & Katch, 1996: 541). BMI, in healthy populations, has a "curvilinear
relationship to the all-cause mortality ratio: as the BMI becomes larger, so also does the risk
of a variety of diseases, such as cardiovascular complications (including hypertension),
diabetes, and renal disease" (McArdle et al., 1996: 541). BMI is a significant predictor of
mortality and morbidity in COPD patients (Gray-Donald et aI., 1996:965). Shoup et al.,
(1997: 1579) found that either abnormally low or high body weight was associated with poorer
health-related quality of life as determined by SGRQ. It is advised that the underweight
COPO patient consult a dietician as weight loss has been found to be reversible with
appropriate therapy amongst COPO patients (Schols, 1998: 1796). Fehrenbach (2002:50)
suggests the combination of exercise with modest weight reduction in COPO patients whom
are overweight. "Weight loss in overweight patients reduces the energy requirements of
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exercise and improves the ability of COPD patients to cope with the condition" (Fehrenbach,
2002:50).
Effects of Hypoxemia and Hypoxia
Hypoxemia is a "reduction in P02 below the normal range, regardless of whether gas
exchange is impaired in the lung, Ca02 is adequate, or tissue hypoxia exists" (Pierson,
2000:50). Normal ranges of P02 are between 9.04 kPa and 10.11 kPa. Hypoxia exists when
there is a shortage of oxygen in the tissues of the body (Pierson, 2000:50). There are several
potential mechanisms for the development of hypoxemia, although in COPD patients the
predominant mechanism is ventilation-perfusion (V/Q) mismatching (Pierson, 2000:50). In
emphysema patients, the total surface area of the alveolar-capillary membrane is reduced and
therefore the pulmonary capillary volume is also reduced, this leads to insufficient oxygen
exchange at the membrane either by insufficient diffusion, or by a decreased contact-time at
increased levels of cardiac output (Folgering and Van Herwaarden, 1994: Il 0). Hypoxia
triggers hypoxic pulmonary vasoconstriction and increases pulmonary vascular resistance. "If
the hypoxia is prolonged, the increased right ventricular afterload produced by the chronically
elevated pulmonary artery pressure results in hypertrophy of the right ventricle" (Pierson,
2000:47). If this process continues, eventually it will cause right heart failure with peripheral
oedema, hepatic congestion and other signs of increased blood volume and elevated central
venous pressure (Pierson, 2000:47). Physiologic responses to hypoxia include increased
ventilation, respiratory alkalosis, pulmonary vasoconstriction, pulmonary hypertension,
decreased maximum oxygen consumption and decreased myocardial contractility (Pierson,
2000:44).
Hypoxemia has an effect on pulmonary vasculature separate from alveolar hypoxia (Pierson,
2000:47)."Reductions in pulmonary capillary surface area caused by emphysema also
contribute to the increased pulmonary vascular resistance. In addition, when present,
erythrocytosis may further augment the pulmonary hypertension" (Pierson, 2000:47).
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Pulmonary hypertension has an adverse effect on survival: the more severe the hypertension,
the worse the prognosis.
Neurologic dysfunction seems to be a prominent manifestation of hypoxia, since the brain is
one of the most oxygen-sensitive organs of the body. "Neuropsychiatiric manifestations of
chronic hypoxia can be a major source of morbidity in patients with COPD" (Pierson,
2000:45). According to Okubadejo, Jones & Wedzicha (1995:44), COPD patients are known
to have impaired cognitive function and to suffer from depression.
Patients with severe COPD complicated by chronic hypoxemia complain of disabling
breathlessness and reduced exercise capacity (Okubadejo et al., 1995:44). Belman
(1993 :940) found that the "major differences between mildly and severely breathless patients
were the presence of hypoxemia during exercise and an abnormally low diffusing capacity in
the latter group." Arterial hypoxemia may directly impair exercise performance by reducing
oxygen delivery to working muscles (Gallagher, 1994:314). In normal subjects the imbalance
caused by exercise in oxygen supply and demand to meet total body energy requirements
leads to fatigue and eventually to task failure (Aliverti and Macklem, 2001 :230). "Because
hypoxia is a ventilatory stimulant, it can also limit exercise indirectly by causing ventilatory
limitation at lower work rate than would occur in the absence of hypoxemia" (Gallagher,
1994:314). However, hypoxia as stated by Aliverti and Macklem (2001 :233-234) is an
unimportant limitation in exercise performance in COPD patients because breathing oxygen
does not restore function to normal. This is possibly due to the reduced gas exchange in
COPD at the alveolar-capillary membrane level. Table 2.3 shows the signs and symptoms of
hypoxia (Pierson, 2000:46).
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Table 2.3 Symptoms and Signs of Hypoxia (Pierson, 2000:46)
Symptoms Signs
(Dyspnea) (Respiratory distress)
Restlessness (Cyanosis)
Palpitations Tachypnea
Confusion Tachycardia
Agitation Cardiac dysrhythmias
Headache Hypertension
Tremor Hypotension
Asterixis Lethargy
Diaphorosis Coma
Symptoms and signs in parenthesis are highly variable among individuals
Steroid Myopathy
Ten (10) - 20% of COPD patients will show an improved FEV1 with use of steroids
(McAllister, 2002b:28). However, the risks of side effects are high. Among the side effects
are myopathy and atrophy of the striated muscles of the limbs (Dekhuijzen & Decramer,
1992:997). Steroid-induced myopathy is also known to reduce muscle strength of the
respiratory muscle groups (Decramer, De Bock & Dom, 1996: 1958). Decramer et al.,
(1997:421) expressed little doubt that the relationship between steroid treatment and muscle
weakness is causal. Decramer et al., (1996: 1961) found that type Ha and lIb muscle fibres
and type I fibres, to a lesser extent, were affected. Steroid-induced myopathy is first noticed
by muscle weakness of the respiratory and peripheral muscles, largely elevated levels of
creatine in the urine, and moderately elevated lactic dehydrogenase levels (Decramer et al.,
1996:1961). Respiratory muscle weakness is noted by enhanced dyspnea. Peripheral muscle
weakness is usually first noticed with elevation of the arms or climbing of stairs. COPD
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patients are more susceptible to muscle weakness as a result of a combination of factors
including cardiac decompensation, malnutrition, electrolyte disturbances and blood gas
abnormalities (Decramer et al., 1996:1958). Dekhuijzen and Decramer (1992: 100I) suggest
that the treatment of steroid myopathy consists of reduced steroid dose and physical exercise
to prevent or reverse steroid-induced muscle weakness.
Hyperinflation
Hyperinflation implies an abnormal increase in the volume of gas in the lungs at the end of
tidal expiration - functional residual capacity (FRC) (Gibson, 1996:2640). Thus an increased
residual volume (RV) and increased ratio of RV to total lung capacity (TLC), also known as
air-trapping in the lungs (Gibson, 1996:2640). "The relaxation volume of the respiratory
system (Vr) [or FRC] increases in patients with chronic airway disease as a result of changes
in the elastic properties of the lungs and chest wall" (Gibson, 1996:2640). Hyperinflation
results from the onset of inspiration before lung volume has fallen to Vr (Gibson, 1996:2640).
"Hyperinflation of the thorax during breathing favors the preservation of maximum expiratory
airflow, because as lung volume increases, elastic recoil pressure increases and airways
enlarge; airway resistance decreases" (Fishman, 1998: 664). Hyperinflation thereby helps to
compensate for increased airway obstruction. However, when the thoracic gas volume is
increased the work of breathing is increased. (Fishman, 1998:664). "Hyperinflation places the
patient on the upper flattened portion of the pressure-volume curve, increasing elastic work;
and the development of auto-PEEP (positive end-expiratory pressure) creates a threshold that
needs to be overcome with each breath" (Mador et al., 2000: 118).
A hyperinflated lung is represented radiographically by a depressed diaphragm and loss of its
normal curvature (Gibson, 1996:2640). The flattened diaphragm is in a disadvantaged
position for optimal function (Scharf, 1992:278). The diaphragm, as well as other inspiratory
muscles, is placed in a shortened position (Scharf, 1992:278; Mador et al., 2000: 118).
Contraction of the diaphragm further flattens the diaphragm and ''the fibers pull the tendon
progressively outward rather than downward, drastically reducing the diaphragm's
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mechanical advantage. Concomitantly, the flattened diaphragm pulls inward on its insertion,
constricting the lower rib cage (Hoover's sign) (Scharf, 1992:278).
Dynamic hyperinflation occurs during exercise and readily develops in COPD patients with
severe airflow obstruction and resting hyperinflation (Fujimoto et al., 2002:457). "Resting
and dynamic hyperinflation influence breathing patterns, inspiratory muscle function and
neuroregulatory control during exercise" (O'Donnell et al., 2002:663). According to Bauerle,
Chrusch & Younes (1998:57) dynamic hyperinflation is also known to be the main
consequence of expiratory flow limitation, especially at high levels of ventilation. A study by
Foglio et al., (2000:260) found that pulmonary hyperinflation was the strongest and most
consistent correlate of impaired exercise performance. Murariu et al., (1998:963) explain that
in normal persons the tidal volume (VT) during exercise is increased at the expense of both the
inspiratory reserve volume (lRV) and the expiratory reserve volume (ERV), although even at
maximum exercise capacity there remains a substantial IRV. In COPD patients, "any increase
in VT during exercise necessarily occurs at the expense of the IRV, and the end-inspiratory
volume eventually approaches the total lung capacity" (Murariu et al., 1998:963). COPD
patients try to compensate for a reduction in their ventilation capacity by increasing their end-
expiratory lung volume (EELV) during exercise to achieve higher maximal expiratory flows,
yet this adaptive response places the respiratory muscles at a mechanical disadvantage (Carter
et al., 1993:745). Because of the increased lung volumes in dynamic hyperinflation, the
inspiratory muscle pressure is increased for a number of reasons (Gallagher, 1994:312). The
inspiratory muscles must generate sufficient pressure to overcome the combined recoil of the
lungs and the chest wall at a higher lung volume for inspiration to take place (Gallagher,
1994:312). The inspiratory muscles also have to generate greater inspiratory pressures,
compared to normal subjects, in order to overcome increased obstruction in the airways.
During exercise the COPD patient has a greater VEat a given work rate that further increases
inspiratory demand (Gallagher, 1994:312). Dynamic lung compliance is significantly reduced
in COPD patients, which results in a further increase in the elastic load (Gallagher, 1994:312).
"The elastic load is increased owing to marked chest wall distortion during exercise"
(Gallagher, 1994:312). Even though the load on inspiratory muscles is notably increased in
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COPD the muscle strength is decreased (Gallagher, 1994:312). Therefore the stress on
inspiratory muscles is remarkably increased in COPD patients during exercise.
During exercise the COPD patient experiences an increase in ventilatory demand, progressive
air-trapping and further dynamic hyperinflation (O'Donnell, Reville & Webb, 2001 :770).
Bauerle et al., (1998:65) found a significant correlation between dynamic hyperinflation and
VE amongst subjects with COPD. Thus the patient who experiences dynamic hyperinflation
will experience concomitant dyspnea and with increased VE, further dynamic hyperinflation
(Bauerle et al., 1998:65; Fujimoto et al., 2002:457). The increased ventilatory requirements
further exacerbate the imbalance between inspiratory muscle load and capacity and the
predisposition to the early onset of respiratory muscle fatigue during exercise (Mador et al.,
2000: 118). Thus COPD patients experiencing dynamic hyperinflation have reduced exercise
capacity. Poor exercise performance is especially evident during arm work compared to
legwork. According to Belman (1993 :938) the stabilising effect ofthe shoulder girdle on the
thorax is lost and inspiratory load is shifted onto the diaphragm and expiratory muscles. The
diaphragm is required to assume a greater load, and as explained above, does not have the
capacity to do so. This has important implications for COPD patients in activities of daily
living (ADL) (Belman, 1993:938). "High inflation volumes may also affect cardiac
performance and, thus, peripheral muscle function during exercise" (O'Donnell et al.,
2001:770).
Diaphragmatic Fatigue
"Respiratory muscle fatigue has been implicated in predisposing patients with advanced
pulmonary disease to respiratory insufficiency" (Baum and Wolinsky, 1994:1229). "The
diaphragm is the principal respiratory muscle, both because of its unique function in
depressing the floor of the thoracic cavity and because of its effectiveness as an inspiratory
muscle. The diaphragm is virtually always active during inspiration" (Scharf, 1992:278).
The diaphragm consists of striated skeletal muscle and is predominantly made up of slow
twitch muscle fibres and fast twitch oxidative glycolytic fibres (West, 1995: 135). These fibres
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are relatively resistant to fatigue but respiratory failure can occur if the work of breathing is
increased over prolonged periods of time (West, 1995:135). Hyperinflation places the
inspiratory muscles, particularly the diaphragm, in a shortened position and at a mechanical
disadvantage. "During exercise, ventilatory requirements increase, further exacerbating the
potential imbalance between inspiratory muscle load and capacity" (Mador et al., 2000: 118).
Thus, COPO patients may be "particularly predisposed to the development of inspiratory
muscle fatigue during exercise" (Mador et al., 2000: 118).
West (1995: 135) reports on patients with severe COPO who continually breathe close to the
work level at which fatigue occurs. "Fatigue is defined as the inability of a muscle to
maintain a given force" (Bates, 1989:374). Increased ventilatory demand, during exercise or
during an exacerbation of infection, will tip these patients over into a state of fatigue (West,
1995: 135). A state of diaphragmatic fatigue will result in hypoventilation, CO2 retention and
severe hypoxemia. According to West (1995:135) a vicious cycle is initiated as hypercapnia
impairs diaphragm contractility and severe hypoxemia accelerates the onset of fatigue.
Malnutrition and steroid use also has a part in diaphragmatic muscle weakness. However,
according to Dekhuijzen and Decramer (1992:997), the extent to which steroid use
compromises diaphragm muscle fatigue is not fully understood.
Clinical manifestations of diaphragm fatigue include "tachypnea, paradoxical abdominal
motion and respiratory altemans (variations between normal expansion and abdominal
paradox), hypercapnia, and as a preterminal event, bradypnea" (Bates, 1989:374). It is
possible to limit the dangers of diaphragm fatigue by reducing the work of breathing with
treatment of the bronchospasm and controlling infection and by giving the patient oxygen to
relieve hypoxemia (West, 1995:123).
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Hypercapnia and Acidosis
Hypercapnia commonly accompanies severe airway obstruction, although it is generally not
dangerous when blood pH is near normal (Celli, 2003b). Normal pH is between 7,35 and
7,45 (Zawada, 2003: no page number). Hypercapnia occurs due to two mechanisms, carbon
dioxide (C02) retention from hypoventilation and ventilation-perfusion (VIQ) inequality
(West, 1995:133). VIQ inequality is generally the culprit in severe COPO (West, 1995:134).
Thus COPD patients must breathe more to maintain blood gases and pH, but cannot breathe
as much as a normal subject due to obstructed airways as a direct result of COPD. Therefore
C02 is retained and the body's pH level lowered. Respiratory acidosis is caused by CO2
retention from alveolar hypoventilation, which results from a depressed central respiratory
centre, restricted chest wall mobility and reduced pulmonary alveolar surface area (Zawada,
2003:no page number). COPO patients are at risk due to their poor ventilatory capacity to
respond to hypercapnia or hypoxia (Zawada, 2003 :no page number). "Respiratory acidosis is
often accompanied by hypoxia" (Zawada, 2003:no page number).
Metabolic acidosis is a condition "characterized by a primary decrease in extracellular fluid
bicarbonate; serum pH and carbon dioxide content are decreased" (Zawada, 2003:no page
number). Metabolic acidosis occurs in COPD patients at rest and most often coexists with
respiratory acidosis which complicates the pH abnormality further (West, 1995: 135). A pH
abnormality "is caused by the liberation of lactic acid from hypoxic tissues, and the dual
factors of hypoxemia and an inadequate peripheral circulation are additive" (West, 1995: 135).
"Metabolic acidosis stimulates ventilation directly because of the fall in arterial pH.
Metabolic acidosis may also increase VE indirectly because of increased CO2 production
owing to buffering of acid" (Gallagher, 1994:315).
Metabolic acidosis develops in normal humans at high work rates but COPO patients tend to
develop metabolic acidosis at lower work rates than normal healthy subjects (Gallagher,
1994:314). Lactic acidosis is a form of metabolic acidosis (West, 1995:32). Lactic acidosis
occurs at the lactate threshold.
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"The term lactate threshold refers to the highest exercise level (intensity) or level of
oxygen that is not associated with an elevation in blood lactate concentration above
the pre-exercise level (or an increase less than 1.0mM [mmol/dl]). The region in
which blood lactate shows a systemic increase equal to or above a level of 4.0mM
[mmol/dl] is termed the point of onset of blood lactate accumulation or simply
OBLA." (McArdle et al., 1996:254)
Exercising muscles produce CO2, which is added to the venous blood.
"The initial response is a linear increase in ventilation to remove this product of
cellular respiration. The coupling is so efficient that arterial CO2and pH change little
during mild and moderate exercise. During aerobic metabolism, muscle C02
production is directly related to oxygen consumption via substrate utilization. With
higher-intensity exercise, lactic acid accumulation triggers additional CO2 formation
due to buffering of hydrogen ion (lactate) by bicarbonate. This leads to accelerated
response in minute ventilation (VE) in relation to oxygen uptake. The steep inflection
in the linear relation between minute ventilation and oxygen uptake is termed the
ventilatory threshold. Only with extreme exercise and high lactic acid production does
metabolic acidemia ensue." (Goldberg & Elliot, 1994:no page number)
Casaburi et al., (1991 :18) showed in their study ofCOPD that the lactate threshold was low in
their patients and arterial lactate increased during unloaded pedalling. It is thought by
Casaburi et al., (1991: 16) that the abnormal pulmonary vasculature in COPD patients
contributes to their inability to supply adequate oxygen to the exercising muscles and thus an
early onset of lactic acidosis during exercise. COPD patients also have a largely increased
oxygen cost of breathing. McArdle et al., (1996:257) state that the cost of breathing during
exercise can easily reach 40% of the total exercise oxygen uptake. Thus there is further
reduction in oxygen available for exercising muscles. COPD patients are most often
untrained; this contributes to the premature development of lactic acidosis seen in these
patients (Casaburi et al., 1991:16). Untrained muscles are known to have higher levels of
oxygen uptake compared to trained muscles at a given work intensity. Exercise training of
COPD patients has shown to result in reduced VE at a given work load and a fall in blood
lactate (Casaburi et al., 1991:16; Gallagher, 1994:315; Maltais et al., 1997:560). Trained
individuals are able to consume greater amounts of oxygen and the anaerobic proportion of
exercise is smaller compared to untrained individuals (McArdle et al., 1996:126). Lung
hyperinflation also plays a role in hypercapnia. In a study by O'Donnell et al., (2002:663), it
Stellenbosch University http://scholar.sun.ac.za
45
was shown that the severe mechanical constraints on ventilation as a consequence of lung
hyperinflation in advanced COPD causes the tendency to develop CO2 retention during
exercise in patients with marked V/Q inequalities. Jonville, Delpech & Denjean, (2002)
investigated the contribution of acidosis to exercise-induced diaphragmatic fatigue by
measuring the twitch mouth pressure response to cervical magnetic stimulation of the phrenic
nerves (this allows reliable and non-invasive measurement of respiratory strength during
nonvolitional contractions). The subjects were required to perform two cycle tests, one while
breathing spontaneously and the other test while voluntarily hypoventilating. Jonville et al.,
(2002: 1082) found the test performed while voluntarily hypoventilating resulted in
significantly increased mean carbon dioxide in arterial blood and significantly decreased
arterial pH when compared to spontaneous breathing. After the lO-minute spontaneous
breathing test, the twitch mouth response was unchanged compared to the baseline values
whereas the twitch mouth response fell significantly compared to baseline after the
voluntarily hypoventilating test. The results of the study suggest that "exposure to
hypercapnia may impair respiratory muscle function. This impairment could be more
clinically relevant in patients with chronic obstructive lung disease" (Jonville et aI.,
2002:1084).
"If muscle metabolism reaches its limits owing to a lack of oxygen, muscle metabolism is
forced to anaerobic energy delivery, resulting in intramuscular acidosis thus terminating
exercise" (Gosse link, Troosters & Decramer, 1996:978).
"Accompanying this blood lactate accumulation is a dramatic increase in Ir
concentration in the active muscle, which can dramatically affect the intracellular
environment. These alterations in contractile function are related to a depletion of
intramuscular high-energy phosphates, an impaired glycolytic energy transfer capacity
owing to the reduced activity of key enzymes, a disturbance in the tubule system for
transmitting the impulse throughout the cell, and ionic imbalances. Certainly a change
in Ca+ [calcium ions] distribution could alter the activity of the myofilaments and
impair muscular performance. This would cause fatigue even though nerve impulses
continue to bombard the muscle fiber." (McArdle et al., 1996:351)
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Muscle fatigue occurs at reduced exercise intensities due to the early onset of lactic acid as a
result of an accumulation of factors, primarily being the V/Q inequality that tends to occur in
COPO patients. Thus, the lowered lactate threshold contributes to the low levels of exercise
tolerance often experienced by COPO patients.
Symptoms of progressive respiratory failure are: metabolic encephalopathy with headache,
drowsiness, and ultimately stupor and coma (Zawada, 2003). "Asterixis and myoclonus may
develop" (Zawada, 2003).
Deconditioning
Oue to shortness of breath during exercise, COPO patients tend to develop a sedentary
lifestyle (Agusti et al., 2003:351). As a result of reduced activity "COPO patients are subject
to varying degrees of deconditioning" (Franssen, 2003:no page number). Physical inactivity
causes a loss of muscle mass, reduced force generating capacity of muscle and decreased
resistance to fatigue (Agusti et al., 2003:351). Deconditioning is a common problem in
COPO patients and often aggravates exercise tolerance (Belman, 1993:940). This initiates the
"vicious cycle" of deconditioning (Clark, Cochrane & Mackay, 1996:2594). This "vicious
cycle" occurs in COPD patients who have significantly reduced levels of physical activity and
often avoid exertion due to dyspnea (Steiner and Morgan, 2001 :73), due to this reduction in
activity their exercise capacity is further decreased and patients then reduce their levels of
activity even further. Celli (1999: 196) states that the effect of training is lost after the
exercise is stopped. Celli (1999: 196) also mentions that it has been shown that bed rest
resulted in a significant decrease in maximal oxygen consumption within 21 days. Atrophy
occurs in COPD patients of both muscle fibre types as a result of deconditioning (Franssen,
2003:no page number). There is also a decline in oxidative enzyme activities in COPO,
which is thought to be as a result of deconditioning (Franssen, 2003:no page number). Both
contractile protein synthesis and activity of enzymes controlling energy metabolism are
dependent on activity.
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Cardiac Impairment
There is a large amount of evidence of abnormal cardiovascular responses to exercise in
COPO patients. In COPD the pulmonary vascular resistance and pulmonary artery pressures
are increased (Aliverti and Macklem, 2001 :234) at rest. Elevated vascular resistance occurs
mainly as a result of remodelling of the muscular arteries and arterioles, although
emphysematous destruction of the vascular bed, alveolar hypoxia, increased haematocrit and
acidosis also playa role (Belman, 1993:938). The right ventricular ejection fraction fails to
increase during exercise in COPO even though:
"right ventricular end-diastolic volume is increased; and left ventricular end-diastolic,
end systolic and stroke volumes are decreased, presumably secondary to the failure of
the right ventricular ejection fraction to increase, or competition for space between the
two sides ofthe heart within the pericardium." (Aliverti and Macklem, 2001 :234)
The right ventricular dysfunction is measured either by stroke volume-to-end diastolic
pressure or right ventricular ejection fraction (Nici, 2000:698). According to Nici (2000:698)
the causes for right ventricular dysfunction include:
"pulmonary hypertension, hypoxia, acidosis, and passive elevation of pulmonary
artery pressure from left ventricular (LV) causes. In addition, the effects of
intrathoracic pressure changes and extensive decreases in pleural pressure during
inspiration can cause elevation of RV [right ventricular] afterload and RV [right
ventricular] distention." (Nici, 2000:698)
Barbera et az', (2003:897) suggest that since pulmonary hypertension may develop at
moderate levels of exercise, "repeated episodes of pulmonary hypertension during daily
activities for example climbing stairs or even walking, could contribute to the development of
right-ventricular hypertrophy".
Cardiac output (QT) appears to increase normally during exercise in patients with COPD
however at peak exercise, QT is about 50% of what a normal subject could achieve by
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reaching a higher V02 (Agusti, 2003:354). According to Gallagher (1994:314), although QT
response to exercise is normal, stroke volume (SV) is less and heart rate is greater in COPD
subjects compared to normal subjects at the same V02. Aliverti and Macklem (2001 :234)
report on findings of decreased QT during exercise to 39% of predicted, although they also do
comment on the variability between patients suggesting that the severity of expiratory flow
limitation is an important determinant of exercise QT. The O2 uptake per heartbeat or O2
pulse is characteristically low in COPD patients and may be a major factor limiting exercise
performance (Nici, 2000:698). The low O2 pulse is likely to be due to the low SV, which is as
a result of the loss of pulmonary capillary bed (Nici, 2000:698). Aliverti and Macklem
(2001 :234) discussed the study of Morrison et al., (1987) who found strong correlations
between exercise O2 consumption in COPD and right ventricular ejection fraction, exercise
stroke volume and exercise cardiac output. Inadequate O2 delivery is an important
determinant of the impairment in exercise performance in COPD (Aliverti and Macklem,
2000:234). Aliverti and Macklem (2000:234-235) found that blood flow to the legs was not
impaired in COPD subjects with peripheral muscle dysfunction, however they believe that the
early lactate production that limited exercise could be related to the diminished capacity of
exercising muscles to extract O2. Aliverti and Macklem (2000:235) concluded in their review
of published literature that "poor exercise performance is due to failure to deliver oxygen to
the exercising muscles. As this is not corrected by breathing oxygen, this failure must be due
to relative ischemia" in the muscles, as mentioned above.
PULMONARY REHABILITATION
Introduction
The British Thoracic Society (1997:S 13) defines rehabilitation as "the restoration of the
individual to the fullest medical, mental, emotional, social and vocational potential of which
he/she is capable". AACVPR Pulmonary Guidelines Panel (1997:1364) defines pulmonary
rehabilitation as:
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"An art of medical practice wherein an individually tailored, multidisciplinary
programme is formulated which through accurate diagnoses, therapy, emotional
support, and education, stabilizes or reverses both the physio- and psychopathology of
pulmonary diseases and attempts to return the patient to the highest possible functional
capacity allowed by his pulmonary handicap and overall life situation."
The common goal of pulmonary rehabilitation is to restore the patient to the highest possible
level of independent function (Toshima, Kaplan & Ries, 1990:238; Cox et al., 1993: 236;
ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel, 1997:1363; Ketelaars et al.,
1997:363). This primary goal includes relieving symptoms, particularly dyspnea; improving
functional ability and enhancing HRQL (Mahler, 1998:263S). Studies have shown that these
goals are achievable. Foglio et al., (1999a: 128) found in their study of pulmonary
rehabilitation that COPD patients in an outpatient setting had short-term improvements in
exercise tolerance, dyspnea and quality of life. Wijkstra et aI., (1995:827) found that long-
term improvements in quality of life were sustained for up to 18 months after a three-month
rehabilitation programme. A study by Bendstrup et aI., (1997 :2805) confirmed that an
economical, comprehensive, and well-tolerated rehabilitation programme "can improve
activities of daily living, quality of life, and functional capacity in patients with moderate-to-
severe chronic obstructive pulmonary disease". It is not entirely clear whether the
improvements noted after pulmonary rehabilitation are "due to physiological changes such as
improved neuromuscular coordination producing more efficient walking pattern or to
predominantly psychological factors such as increased tolerance of dyspnea" (McGavin et al.,
1977: abstract). According to evidence-based guidelines by the ACVPR (1998:3), the
following outcomes of pulmonary rehabilitation were demonstrated:
• Reduced hospitalizations and use of medical resources
• Improved quality of life
• Reduced respiratory symptoms (e.g. dyspnea)
• Improved psychosocial symptoms (e.g. reversal of anxiety and depression and
improved self-efficacy)
• Increased exercise tolerance and performance
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• Enhanced ability to perform activities of daily living
• Increased survival in some patients
• Return to work for some patients
It has been found in the review of literature that pulmonary rehabilitation is not entirely
uniform but instead many researchers and authors have a unique set of components that make
up pulmonary rehabilitation. The ATS (1999) suggests exercise training of the aerobic
system, upper extremity endurance, lower extremity endurance and strength training as well
as respiratory muscle training. The ATS (1999) also suggests the use of education and
psychosocial and behavioural intervention in pulmonary rehabilitation. The ACCP/AACVPR
Pulmonary Rehabilitation Guidelines Panel (1997) has similar components of pulmonary
rehabilitation. There has also been mention of pulmonary rehabilitation, which includes
smoking cessation therapy (Bendstrup et al., 1997:2801), breathing retraining, evacuation of
mucus, relaxation techniques and recreational activities (Cambach et al., 1997: 104).
Calverley and Pride (1995:528) recommend the use of pharmacological therapy, education,
physical therapy (breathing retraining, relaxation techniques, mobilization techniques,
postural drainage, vibration and coughing), exercise conditioning, occupational therapy
(ergonomics and vocational therapy), psychosocial support (counselling,
psychopharmacological agents, group therapy, support of family, sexual counselling), oxygen
therapy (if necessary), nutritional therapy and respiratory muscle training. Cell i (1995) uses
exercise training, respiratory muscles and breathing retraining, training of pursed lip and
diaphragmatic breathing, education and psychological support. Of all the components of
pulmonary rehabilitation, the ATS (1999: 1671) states that exercise is the foundation of
pulmonary rehabilitation.
Exercise in Pulmonary Rehabilitation
Exercises in pulmonary rehabilitation are known to include components such as interval
training, endurance training, strength training of both upper and lower extremities,
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desensitisation to dyspnea and training in ADL's. The most frequently mentioned
components are endurance and strength training.
Strength Training
Hamilton et al., (1995 :2023) found, in a comparison of normal subjects with cardiorespiratory
impaired subjects, that respiratory and peripheral muscle strengths, normalized for differences
in age, gender and height, were significantly less in subjects with cardiorespiratory
impairment compared to the normal group of subjects. Several factors contribute to
peripheral muscle weakness. These weakening factors include hypoxemia, hypercapnia,
steroid treatment, inactivity, and malnutrition. Inspiratory muscle function is also weakened
due to the mentioned factors and is compromised even further as a result of hyperinflation of
the lungs in some COPD patients (Gosselink et al., 1996:978).
"The hypoxia that many COPD patients develop with exercise may limit exercise by reducing
oxygen delivery to working muscles" (Gallagher, 1994:314). The abnormal cardiovascular
function of most patients with moderate or severe COPD often limits exercise performance
(Gallagher, 1994:317) because of the body's inadequacy to deliver sufficient oxygen to the
muscles. According to a statement made by the ATS and the European Respiratory Society
(1999:S6), studies of oxygen transport and oxygen utilization in COPD patients indicate that
both oxygen delivery and oxygen uptake of the legs at peak exercise are limited most likely as
a result of complex interactions involving central and peripheral (impaired oxidative capacity)
factors. However, it appears that the blood flow and oxygen delivery to the legs during
submaximal exercise is preserved and not any different from blood flow and oxygen delivery
in untrained healthy subjects (A statement of the ATS and European Thoracic Society,
1999:S6).
"If muscle metabolism reaches its limits owing to lack of oxygen, muscle metabolism is
forced to anaerobic energy delivery, resulting in intramuscular lactic acidosis" (Gosselink et
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al., 1996:978). COPO patients were found to have significant lactic acidosis at low work
rates (Casaburi et al., 1991: 15-16). Maltais et al., (1996:444) also found that compared to
normal subjects, COPO patients show decreased skeletal muscle oxidative capacity and early
exercise-induced lactic acidosis for a given work rate. Acidosis is thought by Gallagher
(1994:317) to contribute to exercise limitation by impairing cellular function.
Nutritional status also has an effect on limb muscle strength and endurance (Belman,
1993:940). Malnutrition correlates significantly with low peripheral muscle strength. The
reduced daily activities in COPO patients leads to a concomitant reduction in muscle function
(Simpson et al., 1992:70). Once the muscles are deconditioned, the COPO patient is likely to
further reduce the daily activities performed and hence cause a downward spiral as the
functional status of the COPO patient is reduced. However, it is evident from previous
research that poor muscle strength amongst COPO patients is partially reversible and
complements a purely aerobic exercise programme.
A study by Bernard et al., (1999: 159) compared two groups of COPO patients on a 12-week
exercise programme. One group of patients performed an aerobic only training programme
and the other group a programme of aerobic exercise combined with upper and lower body
strength training. Bernard et al., (1999:900) concluded that the addition of strength training to
aerobic training in pulmonary rehabilitation is associated with significantly increased muscle
strength and mass, but does not provide additional improvement in exercise capacity or
quality of life. Clark et al., (1996: 2590) compared a group of 32 COPO patients, who
performed a 12-week training programme including peripheral muscle endurance and strength
training, with a control group of 16 subjects. Clark et al., (1996:2593) found significant
improvements in the experimental group compared to the control group, in peripheral muscle
endurance and strength and in a walking test. Clark et al., (1996:2595) stated that the
"benefits include not only increased endurance both of specific muscle activities and
submaximal work, such as walking, but also reduced ventilation and breathlessness during
exertion". As these are important functions of daily living they should be key aspects in the
training of COPO patients (Clark et al., 1996:2595)
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The benefits of strength training are elaborated in the following two sections of literature.
1. Upper Extremity Strength Training
It was found by Lareau et al., (1992:A476) that COPO subjects tended to perform arm
activities that require the least respiratory muscle demand more frequently than those
activities requiring sustained unsupported arm extension (washing hair, for example) or which
require restricted diaphragmatic movement (bending forward to put on socks, for example).
Lareau et al., (1992: A476) concluded that arm activities that alter respiratory mechanics are
limited in patients with severe COPO. According to Clark et al., (1996:2596), in their study
of weightlifting exercises in patients with COPO, activity of the upper limbs has a negative
effect on diaphragmatic function. "During arm work the stabilising effect of the shoulder
girdle on the thorax is lost and the inspiratory load is shifted onto the diaphragm and muscles
of expiration" (Clark et aI., 1996:2594). The diaphragm is then required to assume a greater
load even though the diaphragm is not sufficiently prepared to do so. The net result is that
there is a greater limitation of arm than of leg exercise associated with the earlier onset of
dyspnea (Clark et al., 1996:2956).
A large number of studies have shown excellent results after upper extremity resistance
training. The dyspnea experienced by COPO patients when performing activities using their
upper extremities can be reduced by anchoring the arms so that the "muscles of the shoulder
girdle (e.g. pectoralis major) can pull on the rib cage and contribute to ventilation. Upper
extremity exercise training can augment the strength and endurance of these muscles, and
thereby enhance inspiration" (Mahler, 1998:266s). Couser, Matinez & Celli, (1993)
performed research on the effect of pulmonary rehabilitation that included upper extremity
training. The research by Couser et al., (1993:39) indicates that pulmonary rehabilitation
which includes arm exercises significantly reduces the metabolic and ventilatory demands of
a simple arm exercise in patients with COPO.
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"Arm training also increases the capacity to perform arm work and decreases oxygen
uptake [V02] for a similar amount of work. The exact reason for these changes is not
clear. Possible mechanisms include desensitization to dyspnea, better coordination of
the muscles partaking in arm elevation, and true metabolic adaptations."
(ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel, 1997:1369)
Ries, Ellis & Hawkins, (1988:691) believe that a cross-over effect occurs between upper-
extremity and ventilatory muscle function. In other words, an improvement in ventilatory
muscle endurance occurs after upper body exercises (Ries et al., 1988:691). However, a
difference between unsupported arm training (against gravity) and arm-cranking was noted by
Celli (1998:no page number). Celli (1998:no page number) found that unsupported arm
training decreases oxygen uptake at the same workload compared with arm-cranking.
Therefore, resistance training, preferably unsupported, of the upper extremities is an effective
means of reducing the ventilatory and metabolic demands of daily activities that require the
use ofCOPD patients' upper extremities.
Strength training of the upper extremities is encouraged for improved functional status in
COPD patients. If the arms are trained to perform more work (or if the ventilatory
requirement for the same work is decreased), the capacity to perform activities of daily living
is likely to improve (Celli, 1998:no page number). The ACCPI AACVPR Pulmonary
Rehabilitation Guidelines Panel (1997: 1369) believes that "arm exercises are safe, and should
be included in rehabilitation programmes for patients with COPD". The ACCP/AACVPR
Pulmonary Rehabilitation Guidelines Panel (1997:1371) concluded that: "the addition of arm
training to leg training resulted in significant improvement in functional status when
compared to either exercise alone."
2. Lower Extremity Strength Training
According to the literature, COPD patients are often limited during exercise by leg muscle
fatigue rather than by dyspnea (Haccoun et al., 2002: 1079). Killian et al., (1992:939)
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concluded from their study of weightlifting in patients with chronic airflow limitation that
subjects were limited by the severity of leg muscle effort or fatigue more often than they were
limited by dyspnea during an incremental exercise test. Killian et aI., (1992:939) suggested
that COPD patients are likely not to be able to reach an adequate training response due to the
severity of exercise-induced symptoms and it may lead to their dropping out of exercise
programmes. In a statement made by the ATS and the European Respiratory Society
(1999:S4), approximately 70% of chronic lung disease patients have lower quadriceps
strength than the mean value obtained in normal subjects of similar age. Compared to
subjects of similar age COPD patients have 20 to 30% less strength in their quadriceps
muscles (A Statement of the ATS and European Respiratory Society, 1999:S4).
The benefits of lower extremity strength training are well documented. Bernard et al.,
(1999:898) found significant reductions in VE, heart rate and arterial lactate concentration for
a given exercise work rate after strength and aerobic training of COPD patients. Bernard et
al., (1999:899) also noted a large improvement in the 6MWT. Bernard et al., (1999:899)
stated that improved peripheral muscle strength "may enhance exercise tolerance in patients
with COPD. A greater strength of the quadriceps femoris muscle after training may reduce
the perception of muscle fatigue, a common limiting symptom during exercise in patients with
COPD". Levels of dyspnea are reduced for a given work rate after strength training and are
believed by Mahler (1998:265S) to be as a result of the corresponding fall in ventilatory
demand during exercise (decreased VE / work rate) as a result of enhanced mechanical
efficiency. Lung function, however, does not improve after following of exercise
programmes for the lower extremities (ACCP/AACVPR Pulmonary Rehabilitation Guidelines
Panel, 1997:1365). Clark et al., (1996:2594) found that low intensity exercises had benefits
including increased endurance both of specific muscle activities and submaximal work, such
as walking, as well as reduced ventilation and breathlessness during exertion. Walking is an
important function of daily living and is generally a key target for training in patients with
COPD (Calverley and Pride, 1996:2595). Another advantage of strength training is that it
may encourage an increase of bone density in COPD patients - in whom osteoporosis is
highly prevalent (Bernard et al., 1999:900). Bernard et al., (1999:900) also found that muscle
resistive exercises induced little dyspnea and were well tolerated by COPD patients. The
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resistive exercises also helped to diversify the training session and maintain patients' interest
and motivation. The AACP/AACVPR Pulmonary Rehabilitation Guidelines Panel
(1997: 1369) concluded that: ''there is substantial evidence that lower extremity exercise
training should be included on rehabilitation programmes for patients with COPO. Benefits
may be both physiologic and psychological".
Aerobic/ Endurance Exercise
"Endurance exercise training is the most important aspect of rehabilitation for patients with
chronic pulmonary disease" (Cooper, 2001 :S671). Aerobic exercise well above the anaerobic
threshold is known to increase maximal exercise performance, cause physiologic adaptations
in peripheral muscles and improve cardiac function (ATS, 1999: 1671). Although exercise to
date has not resulted in measurable effects on the underlying respiratory impairment, it has
positive effects on dyspnea that underscores the importance of deconditioning as a co-morbid
factor in advanced lung disease (ATS, 1999:1671). Maltais et al., (1997 :556) believe that
improvements in exercise capacity as a result of endurance training can "usually be
attributable to better motivation, desensitization to dyspnea, improved technique and
performance, and, more recently, to enhanced respiratory muscle function".
Walking is necessary for most activities of living and thus is the preferred mode of training
for many rehabilitation programmes (Celli, 2003a:no page number). "Because of training
specificity, exercise programmes should provide training that parallels the desired outcome(s)
as closely as possible" (ATS, 1999: 1672). The "specificity principle" of training maintains
that aerobic or cardiovascular exercise elicits specific endurance training adaptations, with
only a limited interchange of benefits derived between strength and aerobic training (McArdle
et aI., 1996:393-394). McArdle et aI., (1996: 393-394) advise that during specific activities,
for example, walking, the overload must engage the appropriate muscles required by the
activity and induce an exercise stress on the central cardiovascular system. Gosselink et al.,
(1997:2886) agree that the principle of ''training specificity" implies that the "work during
exercise training should resemble conditions that are needed to be improved in COPD
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patients, i.e. activities of daily living." Maltais et al., (1997:559) also encourage treadmill
walking as a training modality because of its importance in daily living. Physical limitations
may restrict the types of exercise training that can be used and although walking is the
preferred exercise type, "some people may prefer exercising on a stationary bicycle" (Celli,
2003a:no page number). Cooper (2001 :S671) suggests the mode of aerobic exercise should
use large muscle groups of the legs (e.g., treadmill or cycle). A transfer effect has been
shown when cycle ergometer training improved walking distance (Gosselink et al., 1997:
2887). Celli (2003a:no page number) comments that it is important to choose an exercise that
is comfortable and satisfying for the person in order to enhance long-term compliance.
Similar duration, intensity and frequency of exercise sessions are recommended throughout
published literature. Clark (1994:276) recommends aerobic exercise of 20-30 minutes, three
times a week. ACSM (2000:201-202) suggests intermittent exercise if necessary for the
initial training sessions until patients can achieve sustained physical exertion. Cooper (2001 :
S671) and Mink (1997:no page number) are in favour of an accumulation of 30 minutes of
exercise per exercise session at the target intensity, achieved by either continuous or interval
training. 20 to 30 minutes of interval or continuous aerobic exercise is most often advised in
order to elicit positive effects on COPD patients.
The research findings of optimal exercise intensity vary somewhat more than the generally
agreed upon duration of 20 to 30 minutes' of aerobic exercise. The ATS (1999: 1671)
suggests a high intensity (60 to 80% maximal exercise capacity) alternating with equal
periods of rest. In healthy subjects this form of training elicits training effects similar to those
of endurance training, but it seems that its effect on COPD patients is unclear. Mink (1997 :no
page number) suggests that patients should aim to exercise at 60% to 80% of their maximum
heart rate. It was realised by Mink (1997:no page number) that this goal may not be
achievable for months, if at all. Mink (1997:no page number) recommends that the patient's
capacity should be used as a guide. "If at first he or she can only exercise for 5 minutes - or
even as little as 2 minutes - build on that. Patients should progress slowly; even small
increments can make a significant difference in the quality of their lives" (Mink, 1997:no
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page number). The ATS (1999: 1672) claim that training patients at 60 to 75% of maximal
work rate results in substantial increases in maximal exercise capacity and reductions in
ventilation and lactate levels. Cooper (2001:S671) prefers the use of individual's maximum
oxygen consumption (V02 max.) as a reference for intensity of exercise. Cooper (2001 :S671)
exercises COPD patients at a target intensity of 40% of V02 max. Gosselink et al.,
(1997:2888) concluded in their review of exercise for COPD that low intensity exercise
training (approximately 30% of maximal workload) resulted in modest improvements in
submaximal exercise tests, but no improvement in maximal exercise performance was
observed. In contrast, high-intensity training (approximately 60 to 80% of maximal
workload) "improved both maximal and submaximal exercise tests and induced both
cardiorespiratory and peripheral muscle adaptations" (Gosselink et al., 1997:2888-2889). The
review by Gosselink et al., (1997:2889) demonstrated that high intensity exercise training is
possible and safe in COPD patients. Maltais et al., (1997:560) believe differently and
associate high intensity training with increased cardiovascular risk and orthopedic injury and
possibly decreasing compliance with the training programme. The ACCP/AACVPR
Pulmonary Rehabilitation Guidelines Panel (1997: 1369) are doubtful, stating that: "the
optimal specific exercise prescription guidelines for the muscles of ambulation cannot be
defined with certainty at this time". There is clearly uncertainty amongst the researchers
regarding the optimal aerobic exercise intensity in pulmonary rehabilitation.
The use of a subjective scale of perceived exertion (RPE) is often used in pulmonary
rehabilitation. "In the context of pulmonary rehabilitation, dyspnea during exercise testing or
with physical activity during a programme is measured with either a Visual Analogue Scale
(VAS) or Borg Scale that has been modified to measure breathlessness" (AACVPR,
1998:151). The modified Borg Scale has been found to have "strong and significant
correlations with the VAS (Visual Analogue Scale) in patients with COPD (r = 0.99) with VE
(r = 0.98) and V02 [volume of oxygen] during exercise (r = 0.95). It has demonstrated
sensitivity to treatment effects" (AACVPR, 1998:153). The advantages of the Borg Scale are
that the adjectives help patients in selecting the sensation and intensity of the exercise and the
"descriptors facilitate more absolute responses to stimuli and direct interindividual
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comparisons, and the scale has been used in several randomised clinical trials allowing
comparison of findings across studies" (AACVPR, 1998:153).
Gordon (1993:no page number) suggests that patients do not exceed a rate of perceived
breathlessness (RPB) of five in the initial few weeks of the programme. Maltais et al.,
(1997 :561) used the Borg Scale successfully when adjusting the intensity of exercise in a
pulmonary rehabilitation programme. Maltais et al., (1997:557) increased the intensity of
exercise if patients' "Borg score < 5, unchanged in those with a score between a 5 and 6, and
decreased when the score was ::: 7". The technique using RPE provides "a valid tool for
monitoring for intensity of an exercise training programme" (Horowitz, Littenberg & Mahler,
1996:1173). See appendix for a model ofthe Borg Scale.
The frequency of exercise sessions is well documented. Literature suggests exercise
frequency to be at least three times a week for optimal benefits of pulmonary rehabilitation
(Mink, 1997; Ringbaek et al., 2000:153; Cooper, 2001:S671). Ringbaek et al., (2000:153)
found in their study of COPD patients that exercise less than three times a week has no effect
on exercise performance and well being of COPD patients. The duration of rehabilitation
programmes differs amongst the literature but "based on publications after June 2000, the
2003 GOLD Update recommends a duration of::: 2 months for rehabilitation programmes"
(Fabbri and Hurd, 2003: 2).
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CHAPTER 3: STUDY DESIGN AND METHODOLOGY
ETHICAL APPROVAL
The study leaders were required to present a research proposal for approval to the Ethics
Committee for Human Research of the Faculty of Health Sciences of Stellenbosch University.
The study gained ratification by the ethics committee for its commencement, reference
number 2002/C076.
SELECTION OF SUBJECTS
General practitioners and physicians of the Stellenbosch, Somerset-West and Paarl area were
approached by a senior physician to nominate patients with COPD to take part in the study
programme. The study was also advertised in the Somerset-West, Paarl and Stellenbosch
local newspapers. An initial number of 17 subjects were tested for the study. Nine of the
subjects qualified for the study according to the inclusion and exclusion criteria. A senior
physician informed each of the subjects of the study protocol and what their role was in the
study. Subjects were encouraged to continue with any other form of therapy that they were
receiving at the time, for example physiotherapy treatment (these therapies were not
recorded). Subjects were also encouraged to continue with their usual daily routines and to
try to avoid any significant disruptions for the duration of the study. All subjects had to
conform to the predetermined inclusion and exclusion criteria in order to be allowed into the
study.
There was no control group. Each individual served as his/her own control. This is not an
uncommon practice as can be seen in similar studies by well-known researchers published in
very well established journals. Berry et al., (1999), Foglio et al., (1999), Couser, Martinez &
Celli (1993) and Holden et al., (1990) are some of the researchers who published work on
research they did on pulmonary rehabilitation with COPD patients without the use of a control
group. It was unethical to have a control group when most COPD patients were likely to
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benefit from such intervention. It was unethical to help only one group of COPD patients and
not others who are also in desperate need of help. According to a statistician the results of
such a study without a control group can demonstrate significant results.
EXCLUSION CRITERIA
1. Serious illnesses or co-morbidities, for example cancer, chronic arthritis or
claudication of the legs
Serious illnesses or co-morbidities were likely to interfere with exercise training. Pre- and
post-intervention evaluations were likely to be obscured by other illnesses. For example, the
measure of quality of life would be lower due to the other complications combined with the
subjects' COPO status. Subjects were possibly also not able to complete the 6MWT due to
reasons other than COPO, such as osteoarthritis. Post-intervention evaluations may have been
affected by an exacerbation of cancer in the subject, for example. Changes in pre- and post-
intervention evaluations would not be attributable to the status of COPO entirely had there
been other complications.
2. Serious psychological disorders that would interfere with the rehabilitation
process, for example, an inability to learn, severe depression or disruptive
behaviour
The study was designed for subjects with COPO, other complications may have affected the
ability of the subject to complete the exercise programme. Subjects with a psychological
disorder may not have understood the study protocol completely and would perhaps not have
been able to complete some of the tests correctly due to their difficulties in understanding.
Emotional disturbances may also have limited motivation or have interfered with the ability to
perform exercise training. For these reasons, the study outcomes would possibly have been
adversely affected and false impressions would have been given of subjects' complete health
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status. Study leaders were also not trained to deal with psychologically disturbed patients.
The ATS (1999: 1670) strongly recommended that psychologically unstable patients should be
stabilized prior to entering a rehabilitation programme.
3. Known or suspected cases of ischemic disease, angina and right or left heart failure
The presence of ischemic disease, angina and right or left heart failure would have placed
subjects at undue risk during exercise training. The study leaders were not prepared to take
such risks. It was not possible for a physician to be present at every exercise session so the
risk would have been even higher for subjects with cardiac complications.
4. One year or less post tuberculosis (TB)
TB is treated with a six-month course of medication. The changes in subjects with TB could
possibly have been as a result of changes in the TB due to medication (or lack thereof) and
not COPD disease status. Subjects needed to be uniformly COPD patients without
confounding factors that might have altered the validity of the study results.
5. A grade four dyspnea on the Medical Research Council (MRC) dyspnea index (the
criteria for the MRC dyspnea index are included in the appendix)
The physician, who medically screened all subjects before the onset of the evaluations and
intervention programme, graded each subject according to the MRC dyspnea index. It was
thought that subjects with a grade four dyspnea had COPD that was too severe for exercise
without constant physician supervision. The MRC dyspnea index is a commonly used index
and is relatively easily administered by appropriately trained pulmonologists or physicians.
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6. Smokers of less than 10 pack years
Subjects had to have smoked for a minimum of 10 pack years. This was important for the
homogeneity of the subject group.
INCLUSION CRITERIA
1. Subjects were diagnosed with COPD according to the GOLD criteria
The presence of post-bronchodilator FEV I < 80% of the predicted value in combination with
an FEV tlFVC < 70% confirms the presence of COPD according to the GOLD criteria
(Pauwels et aI., 2001: 1257). Subjects with a FEVl of <65% of the predicted normal value
were allowed to participate in the study.
2. Subjects were mobile and could walk a distance of more than 80 metres in six
minutes unaided
The 6MWT was an important measure of functional capacity in the study. Subjects that could
not walk unaided were most likely to be hindered in the 6MWT by musculoskeletal problems
and not necessarily by their COPD status. Subjects with musculoskeletal problems were
unlikely to improve their disease status as they would not have been able to train at exercise
intensities high enough to result in a significant training effect. This would also have affected
the subject's ability to perform a number of the exercises in the intervention programme.
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3. Subjects had to have their own transport and own telephonic communication
Subjects were required to be present at three exercise sessions every week, so subjects without
transport could not be included in the study. It was important that subjects were contactabie
via telephone in cases of rescheduling of exercise sessions, reporting of illness and
absenteeism. Most importantly, follow-up studies, using the same subjects, will rely on
telephonic communication for subject motivation and in order to communicate any
complications that have an effect on adherence to the exercise programme.
4. Subjects were willing to follow a 12-week rehabilitation programme
The programme was staged over a 12-week period. Individuals who missed six exercise
sessions were considered for their continuation of the intervention programme. Thus it was
important that the subjects were committed at the onset of the programme to being present at
all 12 weeks of exercise. 12 weeks of exercise is likely to result in a significant training effect
but periods of absenteeism would interfere with potential gains achieved in the exercise
programme.
5. Age of 45 years and older
Subjects were homogenised by age. Only subjects of 45 years and older were allowed in to
participate in the study.
6. Consent and support of the subjects' personal physician
In order to achieve maximum benefit from the exercise programme it was important that the
study had the support of the subjects' personal physician. The study did not want to create
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any illusions of taking the patients away from their physicians' practice, thus it was important
that physicians were well informed of the study protocol and that their consent was gained. It
was thought that subject adherence would be better if the study had subjects' personal
physician's support. The study leaders informed the subjects' physicians of any
complications that arose during the intervention programme. Subjects were also referred back
to their physicians when necessary, for example, when illnesses or complications were
detected during the intervention programme.
7. Completion and signature of an informed consent document before the
commencement of the study (see appendix)
A senior specialist informed the subjects of the study protocol and what the study required of
each subject. Subjects were issued with informing documents. If subjects agreed to
participate in the study, they were asked to sign a form of consent before commencing with
the initial evaluation procedure. See the appendix for a copy of the patient information and
consent form.
8. Subjects who were in respiratory failure or desaturated to below S.02 of 85%
during the pulmonary evaluation were designated to train on inhaled oxygen
SaOZlevels were monitored continuously during the 6MWT. Subjects who desaturated to
below 85% SaOZwere immediately given supplemental oxygen by way of an oxygen mask
while continuing to complete the test. Subjects who required oxygen in the 6MWT were
designated to use oxygen during the exercises in the intervention programme.
PRE-INTERVENTION PATIENT ASSESSMENT
Persons who were interested in joining the study contacted the clinical practice where all the
testing took place. An appointment was made by interested persons to find out more about
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the study and possibly to perform the pre-intervention tests. On subjects' arrival, a
physicianlpulmonologist explained the study protocol and what the subjects' role would be
within the study. If subjects agreed to participate in the study they were requested to sign a
document of informed consent and they were issued with complete information of the study
protocol. Once this step was completed, a physician performed a medical screening and
examination of each subject. The physician/pulmonologist completed the BDI, physician and
patient global evaluations with the subject. If the subject still fell within the criteria of the
study, the subject was tested further. Subjects who did not qualify for the study were told so
and, if possible, they were asked to return to the study when they conformed to the study
criteria. For example, if their blood pressure was uncontrolled they were referred to their
personal physician and asked to return to the study when their blood pressure was controlled.
The subject's mass and height was then measured and recorded by a clinical technologist. The
pulmonary technologists took the subject's through lung function tests in order to derive the
FEV] on a flow-volume curve. The lung function test was performed three times and the best
value was recorded. Subjects whose lung function measured within the study's inclusion
criteria continued to be given an ECG. FEV] was measured using a Jaeger Master Lab
system, which was calibrated prior to the tests by a three litre jumbo syringe. The volume
signal was integrated to calibrate flow. Subjects were then asked to complete the SGRQ with
guidance of the study leader. Subjects who had completed all the tests successfully at this
point were required to perform the 6MWT. The pulmonary technologist explained the
procedure of the 6MWT to the subject. The subject was then given the opportunity to practice
walking on the treadmill until they felt they had mastered it and were ready for the test. The
subject was rested and then guided by the technologists throughout the test. Subjects' Sa02
levels and heart rate were recorded throughout the walk with the use of a pulse oximeter. The
oximeter used was a BCI Oxi Pulse catalogue number 3301, serial number 320014739.
Patients who desaturated to below 85% were given supplemental oxygen with a facemask.
BP was recorded after each walk. Encouragement was given throughout the 6MWT. The
6MWT was performed three times with sufficient rest between tests. The following 6MWT
was performed when subjects' heart rate and breathing rate had returned to resting values and
the subject felt their legs were well rested. Distances were measured by the treadmill. The
best distance was recorded. If subjects smoked they were recommended to stop and advised
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to consult a clinic for stopping smoking. The subject was thanked and he/she made
appointments to begin their exercise programme. The subject then began the intervention
programme at the Biokinetics centre at the Department of Sport Science, Stellenbosch
University.
INTERVENTION PROGRAMME
The intervention programme consisted of a 12-week exercise programme. Subjects were
required to attend exercise sessions three times a week with no more than six days of absence
in total. Exercises were targeted at improving the patients' deconditioned state as a result of
capo and its morbidities. The exercise programme had components of strength training
exercises for the lower and upper limbs and a component of aerobic exercise. Subjects were
required to perform all exercises at every exercise session.
Upper extremity exercises used resistance In the form of dumbeIIs or wrist weights.
Resistance exercises of the upper extremities targeted the following muscle groups: pectoralis
minor and pectoralis major, upper trapezius, levator scapula, scalene, sternocleidomastoid,
deltoids and biceps. Subjects were encouraged to exhale with the extension of the upper
extremities. The specific muscle groups chosen were in order to improve the ability of
subjects to perform activities of daily living as well as to improve the strength of muscles
used in the process of inspiration. One to three sets of ten repetitions were performed. The
weight of the resistance was established using the Modified Borg Scale of Perceived Exertion.
Subjects used weights equivalent to four (somewhat strong), five (strong) or six on the
Modified Borg Scale. After each exercise subjects were asked to rate the activity on the
Modified Borg Scale. The weight of resistance was adjusted accordingly. For example, if a
subject rated an exercise as four or less on the Modified Borg Scale, the weight was increased
slightly at the next exercise session or if the subject rated the exercise as seven or more, the
weight of resistance was decreased. This method of monitoring exercise intensity was taken
from a study Maltais et aI., (1997:557). Maltais et aI., (1997:558) concluded that this method
was effective in improving exercise capacity; it was safe and was well tolerated by COPD
Stellenbosch University http://scholar.sun.ac.za
68
patients. High-intensity training IS associated with increased cardiovascular risk and
orthopaedic injury and possibly decreases compliance with a training programme (Maltais et
al., 1997:560). Maltais et al., (1997:560) also concluded from their study that the training
intensity used is not influenced by the age of the subject or the severity of the subjects'
airflow obstruction. This method of determining exercise intensity is practically applicable
and can easily be used by subjects in the future when exercising on their own.
Strength training of the lower limbs was included in the exercise programme. Strength
training exercises for the legs was aimed at using gravity and subjects' own body weight as
resistance. Exercises of the lower extremities made use of muscle groups that are used in
ambulation and activities of daily living, namely the quadricep muscle group; hamstring
muscles; gluteal muscles and the hip flexor muscles. The intensity of the exercises was set
according to the Modified Borg Scale of Perceived Exertion. Subjects performed lower
extremity exercises at a RPE of four to six. Exercises to strengthen the abdominal muscles,
rectus abdominus and transverse abdominus, in particular, were also part of the exercise
programme.
Endurance exercises included walking and cycling. Walking was the most highly
recommended activity, as it specifically uses the muscles of ambulation. A number of subjects
in this study had very poor leg muscle strength or experienced joint problems in the lower
extremities. These subjects were limited during treadmill walking due to premature leg
muscle fatigue or joint pain before the subject reached the required intensity of training or a
state of dyspnea. It was then decided to introduce cycling as an alternative form of aerobic
exercise. Study leaders found that these subjects could train on a cycle ergometer at the
optimal intensity according to their heart rate. Muscle groups used to cycle are similar to
those used in ambulation, thus the principle of muscle specificity was applied and the
improvement of leg muscle strength with cycling transferred to the act of walking.
Subjects exercised aerobically at a target heart rate of 60 -75% of maximum. This was taken
from the ATS (1999: 1672). The majority of successful rehabilitation programmes trained
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subjects at 60 - 80% of maximum, as was discussed in chapter three. The use of a maximum
of 75% of maximum heart rate ensured that subjects were not placed at cardiovascular risk
while training. Target heart rate was calculated using the Kamoven method. The maximum
heart rate used in the formula, was determined during the 6MWT. Subjects aimed to maintain
the intensity for 20 - 30 minutes. If subjects were unable to exercise continuously they
exercised intermittently until they could perform the exercise continuously. At first some
subjects could only manage to walk for two minutes at one time so they walked two minutes
then rested and then walked again when they had recovered from the first walk and then
walked again if they felt they could. This was done until gradually their duration of walking
was increased. Subjects were always encouraged to do their best.
SAFETY MEASURES
A number of safety measures were set in place in order to ensure that subjects were not at any
unnecessary health risk and that emergency procedures were swiftly handled. Subjects were
medically screened by a senior physician before entering the study. In this way any abnormal
signs in the subject's health were identified. The inclusion and exclusion criteria were applied
by the senior physician to exclude any subjects who may have been placed at an undue risk by
exercise, for example, subjects with cardiac ischemia, angina or heart failure were excluded
from the study. An EeG was performed on subjects before any form of exercise took place
so cardiac abnormalities could be detected. SaOZwas measured during the exercise test via a
finger pulse oximeter. Subjects who desaturated significantly to below 85% during the
exercise test were either placed on supplemental oxygen or stopped from continuing the test
until supplemental oxygen was given and the subject was able to continue with the test.
Subjects who desaturated during the initial exercise test were designated to use supplemental
oxygen throughout the intervention programme exercise sessions. A senior physician
measured subjects' blood pressure before and after the 6MWT and heart rate was measured
throughout the test by the pulse oximeter in order to detect abnormalities.
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Safety during the 6MWT was vital. The exercise test was terminated under the following
circumstances (ACSM, 2000:104)
1. Drop in systolic blood pressure of 2: 10mm Hg from baseline blood pressure despite an
increase in workload
2. Hypertensive response (Systolic blood pressure of> 250 mm Hg and/or a diastolic blood
pressure of> 115 mm Hg)
3. Subject requests to stop
4. Physical or verbal manifestations of severe fatigue
5. Onset of angina or angina-like symptoms
6. Signs of poor perfusion: pallor or cyanosis
7. Increasing nervous system symptoms (e.g., ataxia, dizziness, or near syncope)
8. Failure of exercise testing equipment
9. Noticeable change in heart rhythm
10. Claudication or leg cramps
Il. Increasing chest pain
Medical supervision was present at the subject evaluations to accommodate any emergencies
that may have occurred.
On arrival at exercise sessions, subjects were seated and their blood pressure was measured
and recorded by a study leader. A Polar heart rate monitor was used on subjects for
continuous monitoring of their heart rate. Heart rate was recorded throughout the exercise
sessions at specified times in order to maintain a record for future reference. Study leaders
where hereby able to detect any abnormalities in heart rate rhythm, i.e. if subjects' heart rate
increased too rapidly, if subjects' heart rate fluctuated drastically, if subjects' heart rate did
not increase at all or even decreased with exercise. Therefore, if abnormalities occurred with
subjects' heart rate rhythm it was possible to refer to the heart rate recordings when referring
subjects to their physician for diagnoses. A physician/pulmonologist and Dr Viviers (from
the student health department) were always available in case of an emergency. The
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physician's and Dr Viviers's telephone numbers were kept close at hand. The physician and
doctor were kept informed of the dates and times at which subjects were exercising. Any
abnormalities in patients which occurred during the exercise sessions were discussed with the
physicianJpulmonologist. Subjects were referred to their personal physician for evaluation if
necessary.
The following contra indications to exercise were used during the intervention programme
(ACSM, 2000: 167):
1. Unstable angina
2. Orthostatic blood pressure drop of>20mm Hg with symptoms
3. Acute systemic illness or fever
4. Severe hypertension at rest (i.e., systolic BP of> 200 mm Hg and/or a diastolic BP of>
110 mm Hg)
5. Uncontrolled tachycardia (>120 beats per min)
6. Uncontrolled atrial or ventricular arrhythmias causing symptoms
7. Uncontrolled symptomatic heart failure
8. Neuromuscular, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
9. Recent acute exacerbation! hospitalisation
10. Uncontrolled metabolic disease (diabetes, for example)
Il. Significant emotional distress (psychosis)
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MEASUREMENTS
Six-Minute Walk Test (6MWT)
The 6MWT was used to evaluate subjects' aerobic functional status at pre and post-
intervention evaluations.
Description
The six-minute walk test required subjects to walk as far as possible in six minutes. Subjects
walked on a treadmill. Clinical technologists, who specialised in pulmonology, tested
subjects on the 6MWT. The test protocol was explained in detail and any questions subjects
had, regarding the test, were answered. If subjects had not used a treadmill before, they were
given time to become familiar with walking on the treadmill. Subjects were then given time
to rest before the test begun. Subjects were encouraged throughout the test to walk as fast as
they could. If the subject said that they wanted to walk faster, or rather slower, the
technologist would adjust the speed of the treadmill accordingly until the six minutes ended or
the test was terminated. Subjects were given sufficient time to recover and the test was
performed again. The test was performed three times and the longest distance walked was
recorded. Subjects used oxygen supplementation if Sa02, as measured by a pulse oximeter,
dropped to a level of below 85%. The threshold of noticeable difference in functional status
is 54 m (Redelmeier et al., 1997:1280). Subjects' blood pressure was measured directly after
the test in order to monitor subjects' cardiovascular response to the exercise. Subjects were
also asked to rate their test on the modified Borg Scale. Subjects' RPE determined the
amount of effort that subjects had placed on their 6MWT. Subjects who rated their RPE as
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below five had obviously not put all their effort into the test and had to repeat the test at a
RPE which was closer to their maximum effort.
Reliability and Validity
The six-minute walk test is a reliable, valid, safe and inexpensive measure (Redelmeier et al.,
1997:1278). The six-minute walk test can also be applied regardless of a patient's age,
gender, or level of literacy (Redelmeier et al., 1997:1278). The test is simple, easy to
administer and uses an exercise mode relevant to everyday activities (Guyatt et al., 1984:818).
"The 6MWT provides information that may be a better index of the patients ability to
perform daily activities than is peak oxygen uptake; for example the 6MWT correlates
better with formal measures of quality of life. Changes in 6MWT after therapeutic
interventions correlate with subjective improvement in dyspnea. The reproducibility
of the 6MWT appears to better than the reproducibility of the I-second forced
expiratory volume in patients with chronic obstructive pulmonary disease." (ATS,
2002a:112)
Stevens et al., (1999:1543) found the 6MWT performed in a hallway and on a treadmill have
similar intratest reproducibility when three walks are performed in a single test session. The
intratest variability of the three hallway 6MWT's was similar to the three treadmill 6MWT's
and no significant difference in the coefficient of variation was found (Stevens et al.,
1999:1543). A study by Knox, Morrison & Muers (1988) of the reproducibility of the 6MWT
over several days indicates that the majority of the increase in walking distance occurs within
the first three tests.
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St George's Respiratory Questionnaire (SGRQ)
The SGRQ was used in our study to assess HRQL of subjects. Subjects were required to
complete the SGRQ before and after the intervention took place. Changes in the pre-
intervention score compared with the post-intervention score indicated a change in the
subject's HRQL.
Description
The SGRQ is a disease-specific questionnaire that measures the quality of life of COPD
patients. The questionnaire is self-administered. It contains 50 items and 76 weighted
responses divided into three components: Symptoms, Activity, and Impacts. The Symptoms
component includes questions concerning the frequency of the patient's cough, sputum
production, wheezing, breathlessness, and the duration and frequency of breathlessness or
wheezing. The Activity component includes items concerning physical activity that cause or
are limited by breathlessness. The Impacts component concerns employment, the feeling of
being in control of health, panic, stigmatisation, the need for medication and its side effects,
expectations for health and disturbance of daily life. The score ranges from zero to 100. The
total score is calculated for each component and a total score for the test is given. Zero
indicates no impairment of quality of life while 100 indicates extreme impairment related to
COPD. The questionnaire takes about 10minutes to complete
Subjects completed the questionnaire in a quiet room where a study investigator was present
to help subjects with any queries. The questionnaire was presented in Afrikaans and in
English. The investigator was careful not to answer the question for the subjects but tried to
help subjects arrive at their own conclusion. The total score was calculated following the
procedures devised by the developers of the questionnaire. A mean change in score of four
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units was associated with slightly efficacious treatment, eight units for moderately efficacious
change and 12 units for very efficacious treatment (ATS, 2002b:no page number). The
advantages of this instrument are that it is self-administered, has computerized scoring, and
has had extensive psychometric testing.
Reliability and Validity
Jones et al., (1992:1326) confirmed in their study that the SGRQ has a good repeatability, it
correlates with a range of established measures of disease activity. The SGRQ is a very
sensitive measure of improvement or deterioration in the health of patients with chronic
airflow limitation. Wilson et al., (1997:536) also state that to date the SGRQ has been shown
to be reproducible, valid and responsive in COPD populations." (Wilson et aI., 1997:536).
Baseline Dyspnea Index (BDI) and Transitional Dyspnea Index (TDI)
The Baseline Dyspnea Index and the Transitional Dyspnea Index are measures of
breathlessness in COPD patients. The BOl was used as an initial evaluation of dyspnea while
the TOI measured change in subjects' dyspnea status after the intervention programme.
Description
The dyspnea indices are multidimensional questionnaires (O'Donnell et al., 1995:2006). The
BOl measures dyspnea at the initial assessment while the TDI is designed to assess changes
after some intervention over time and is related to the initial BDI assessment (Calverley and
Pride, 1995:224). The questionnaires assess three different attributes - functional impairment
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(the degree to which ADL's are impaired), magnitude of effort (the overall effort exerted to
perform activities and the magnitude of task that provokes breathing difficulties. The focus is
on the activity consequences of the individual's breathlessness. "An interviewer uses a
patient history in each category. Ratings on these scales are summed to obtain a focal score"
(Lareau et al., 1994:243). The BOl is out of a total of 12 points: four points per attribute.
Each attribute ranges from zero (very severe impairment) to four (no impairment). Therefore
the higher the score achieved by the subject the less dyspnea is experienced. The TDI was
evaluated after the intervention programme in order to measure change from the BOl score.
Each category receives a score from plus three (major improvement) to minus three (major
deterioration). The total change in dyspnea status (TOI) is then calculated by adding the score
of all three categories, total scores range from minus nine to plus nine (Carrieri-Kohlman et
al., 1996:1528). [See appendix for examples of the questionnaires]. The senior physician
scored subjects on these indices at the first and second evaluation at the beginning of each
evaluation, before the spirometry, SGRQ or 6MWT took place.
Reliability and Validity
The BDI is known to be a valid and reliable measure of breathlessness amongst COPD
patients. "Previous studies have demonstrated the validity and reliability of the BDI in
patients with chronic respiratory disease" (Mahler et al., 1992:396). The TOI has been shown
to detect changes reliably in symptom intervention over time in each of the three categories
(O'Donnell et al., 1995:2006).
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Forced Expiratory Volume in One Second (FEV!)
Forced expiratory volume in one second was measured at both evaluations with the use of a
Jaeger Master Lab. Subjects were seated for the test and a nose clip was used. The severity
of obstructive airways disease is judged on the basis of the absolute value of the FEV 1 or as a
percentage of the predicted FEV 1 (Schorn, 2001:5). Both measurements were recorded for
statistical analysis. The measurement was also to test for reversibility of airway obstruction
with the use of a post-bronchodilator measurement lung function. If the obstruction was
partially or totally irreversible, then the possibility of a diagnosis of asthma could be ruled
out. FEV 1 is the most commonly used measure of disease state.
Description
FEV! is the "volume of air exhaled in the specified time during the performance of FVC, e.g.,
FEV 1 for the volume of air exhaled during the first second of FVC" (ATS, 1987:1287). Lung
volumes are expressed in litres. "In performing the forced expiratory vital capacity
manoeuvre, the person first inspires maximally to the total lung capacity, then exhales into the
spirometer with maximum expiratory effort as rapidly and as completely as possible" (Guyton
and Hall, 1996:539). Subjects were adequately prepared for the test by experienced
pulmonary technologists. The procedure was explained and demonstrated to subjects, who
were then encouraged to make the maximum effort when undergoing the test. The
measurements taken were compared with normal predicted values for age, sex, weight and
height. "An individual with a normal lung will exhale about 80% of the forced vital capacity
(FVC) in 1 s [FEV 1] ... if the airways are obstructed, the rate of flow will be less than normal"
(Prange, 1996:57). The test was performed three times and the best value was recorded. If a
discrepancy of more than 10% was found between the first three tests, further tests were done
until the results could be repeated consistently. The bronchodilator reversibility test was used
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to rule out the diagnosis of asthma. Three puffs of a bronchodilator were administered to
subjects and 15 minutes was allowed for the optimal activation of the medication. The
spirometric test was repeated. The possibility of asthma was considered if the FEV] increased
to more than 80% of predicted normal values. All asthmatics were excluded from the study.
The bronchodilator was only used in the pre-intervention not in the post-intervention
evaluation. Subjects with a post-bronchodilator FEV] of less than 80% of predicted and a
FVCIFEV] ratio of less than 70% of predicted were diagnosed with COPD and qualified for
entry into the study. No changes in FEV] were expected as it is known that the magnitude of
airways obstruction is not a good predictor of response to pulmonary rehabilitation
(ZuWallack et al., 1991:808).
Validity and Reliability
The diagnosis of airflow limitation is based on pulmonary function measurements, commonly
FEV] (Petty and Weinmann, 1997:248). COPD patients with a low FEV] are more likely to
show rapid decline in pulmonary function and are more likely to die from COPD (Croxton et
al.,2002:840). The FEV] is the most commonly used criterion for diagnosis and prognosis of
COPD. FEV] does not, however, reflect any change caused by pulmonary rehabilitation.
Body Mass Index (BMI)
BMI was measured to assess body weight relative to height. Measurements of BMI were
taken before and after the intervention programme to measure any change in relative body
mass.
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Description
BMI is calculated by dividing body weight in kilograms by height in metres squared (kg/nr').
Subjects' height was measured on stadiometer using the metric scale. Subjects' mass was
recorded on an electronic scale in kilograms at pre and post-intervention evaluations. An
example of BMI classification is displayed in the literature review.
Reliability and Validity
The BMI score is repeatable provided the same scale is used for measuring body mass at both
evaluations. BMI scores are easy to obtain and can reliably be used for all individuals of any
gender or age.
Physician Global Evaluation
The physician global evaluation is a physician's assessment of the overall condition of the
patient's COPD status.
Description
The physician's global evaluation is scored from zero to eight with categories of poor, fair,
good and excellent health. The physician bases the score in terms of: concomitant therapy;
number and severity of exacerbations; severity of cough; ability to exercise and amount of
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wheezing. The same investigator at pre- and post-intervention evaluations performed this
assessment.
Validity and Reliability
The physician global evaluation is a measure of respiratory health universally used in COPD
studies and by physicians and pulmonologists. The physician global evaluation is also used
frequently in pulmonological research. An experienced clinician recommended the method of
evaluation. No literature is currently available regarding the physician global evaluation,
however, a number of published studies have used this evaluation in the past. For example,
the randomised double-blind placebo controlled parallel group efficacy and safety comparison
of a one-year treatment of two doses of Tiotropium inhalation solution delivered by a
Respinap inhaler in patients with COPD. 870 patients were randomised, 270 have completed
the trial. This international trial was performed by Boehringer Ingelheim, trial number
205.255.870, at a number of different centres around the world.
Patient Global Evaluation
The patient global evaluation was administered in order to give a further idea of how subjects
perceived their own health.
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Description
The patient global evaluation consists of a thermometer like scale where 100 is absolute
health and zero is the worst level of health. The patient is asked to rate his/her present health
on the scale, as they perceive it.
Validity and Reliability
The patient global evaluation is an easy and quick method of evaluating a subject's perception
ofhislher own health. The patient global evaluation is used extensively in drug trial research.
POST-INTERVENTION ASSESSMENT
The post-intervention evaluation again took place at the same venue as the first evaluation. A
physician first conducted a medical examination on subjects. The physician/pulmonologist
recorded the TDI, patient's and physician's global scores. Subjects' body mass was recorded
by a pulmonary technologist. Subjects then performed the lung function tests. The best of
three lung volumes was recorded. Subjects completed the SGRQ. Subjects were then tested
on their performance in the 6MWT. Again three tests were performed and their best distance
was recorded. The physicianlpulmonologist gave subjects a summary of the changes in their
health over the duration of the study.
DATA ANALYSIS
Each subject served as hislher own control. Results of the second evaluation were compared
with the results ofthe first evaluation. The ANOVA test and the Wilcoxen method were used
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to analyse the data of all the variables tested except the BOl and TOI which were analysed
using the sample t-test.
ABSENTEElSMS AND COMPLICATIONS
The study proved difficult in terms of subjects' handicaps and complications that they
incurred during the intervention programme. Some complications prevented subjects from
attending exercise sessions or forced the study leaders to postpone the date of subjects'
evaluations. Other complications did not stop subjects from attending exercise sessions but
the complications may have hindered subjects' rate of progress in the intervention study. All
subjects, however, continued with the exercise programme and remained motivated to
persevere (apart from one subject) for the duration of the I2-week programme.
Three of the subjects experienced orthopaedic complications during the intervention
programme. One of the subjects fell at home and suffered from a severe haematoma on her
right knee two weeks before her second evaluation was to take place. She was restricted to
bed rest for three to four weeks and her evaluation was postponed by two weeks. A second
subject suffered a grade I sprain to her ankle while she was walking at her home, she was
unable to attend exercise sessions for a week. Two subjects did not disclose the
complications regarding their joint injuries at the first evaluation. One subject had been
involved in an accident a few years previously in which she had incurred severe joint injuries;
these injuries meant that she performed the exercises at a lower intensity and at a slower rate
of progression. A third subject suffered from severe osteoarthritis of the shoulders, knees,
hips and vertebral column. This subject was able to perform all the exercises but it was
advised that he uses the stationery cycle as part of his cardiovascular exercise routine due to
the impact of prolonged walking on his hips, knees and back.
Two of the subjects began to experience atrial fibrillations while exercising. Both subjects
were medicated successfully by their physicians and were able to continue with the
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intervention programme soon after. Another subject was hypertensive, which prevented her
from starting the intervention programme for a week until her blood pressure was controlled
with medication.
Some subjects suffered from acute exacerbations and chest infections. They were usually
treated by their doctors and did not attend the exercise sessions until they had recovered. One
subject suffered from a number of acute exacerbations that forced her to miss more than the
maximum of six sessions. She did, however, remain motivated and continued with the
exercise programme to make remarkable gains in her health, as was measured at the pre- and
post-intervention evaluations.
Two subjects were unable to attend a number of sessions due to business and travel
commitments. One of the subjects was very unmotivated and skipped exercise sessions for
unexplained reasons. She missed a total of nine exercise sessions. The same subject smoked
40 cigarettes a day although she was encouraged to stop on numerous occasions during the
intervention programme. Two other subjects continued to smoke during the intervention
programme, albeit they smoked far less than 40 cigarettes every day. These two smokers
claimed to only smoke about 10 cigarettes in a day. These subjects were not excluded from
the study although their results were likely to have been influenced by their smoking habits
and their absence from a number of exercise sessions.
The inclusion and exclusion of subjects is demonstrated clearly in Figure 4.1 on page 85.
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CHAPTER FOUR: DATA ANALYSIS
SUBJECTS
A total of nine subjects completed the study programme out of 17 subjects who were initially
evaluated. Eight subjects withdrew/dropped out or were ineligible for the study. Two
subjects suffered from claudication upon performing the exercise test. These subjects were
unable to continue with the intervention programme until they had received further medical
attention. These two subjects were referred to vascular specialists but did not return to the
study for reasons unknown to the study leaders. A third subject was unable to walk without a
walking frame. This person was excluded from the study according to the study's
predetermined exclusion and inclusion criteria. Another subject presented with an Achilles
tendon rupture and was unable to perform the exercise test or any further exercise
intervention. A fifth subject who qualified for the study left shortly after the initial evaluation
for an extended overseas holiday and did not return. The sixth subject decided for his own
personal reasons that he did not want to participate in the study. The seventh subject qualified
according to the criteria set for the study but lung function tests showed that her FEV 1 was
normal (more than 80% of the predicted normal value) and was not low enough to qualify for
the study. The final subject who did not complete the intervention programme did qualify for
the study but she dropped out after two weeks due to the expense of travelling to the exercise
venue three days in a week for 12 weeks. In total, nine subjects completed the intervention
programme. Figure 4.1 provides an illustration of the subjects who dropped out, were
ineligible and those who completed the intervention programme.
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n=17
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Subjects ineligible/ did Subjects elligible
not consent n=7 n=10
/ -, ~
Subjects referred Subject with Drop outs
for other medical orthopaedic limitation n=l (after 2
attention n=3 n=l weeks)
~Subject with Subjects did not
Total subjects toFEV! sn=I consent n=2
complete study
n=9
Figure 4.1. Subjects who dropped out, were ineligible and those who completed the
intervention programme.
SUBJECT DEMOGRAPIDCS
The study group consisted of nine subjects, five male subjects and four female subjects. At
the onset of the study subjects' age ranged from 45 years old to 78 years old. The mean age
was 67.78 years. All subjects were of Caucasian race. The minimum number of pack years
was 16 and the maximum was 100. Three of the subjects were current smokers. Six of the
subjects were in the third category (short of breath walking with others of similar age and
physique, even on level ground, do own shopping) of the MRC dyspnea index, three subjects
were a two (troubled by inclines or when hurrying on level ground) on the same index. Five
subjects fell into the HA category according to the GOLD COPD staging criteria. This meant
that their FEV! was more than 50% but less than 80% of predicted, with or without
symptoms. All subjects showed symptoms of COPD (cough, sputum production and
dyspnea). Three subjects were in the category of lIB - their FEV! was more than 50% but less
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than 800!o of the predicted norm. One subject was a grade III (severe) COPD according to the
GOLD disease staging criteria. This subject's FEY) was less than 30% of predicted. This
particular subject was the only subject to use oxygen at home and while training. The patient
demographics are shown below in Table 4.1.
Table 4.1. Patient Demographics
N. Gender Age Race Pack MRC dyspnea Oxygen GOLDCOPD
Years index staging of severity
1. Male 70 White 16 3 No liB: Severe
2. Male 78 White 20 3 No HA: Moderate
3. Female 76 White 54 2 No HA: Moderate
4. Female 70 White 100 3 No HA: Moderate
5. Male 45 White 50 2 No HB: Moderate
6. Male 73 White 20 3 No HA: Moderate
7. Female 78 White 90 3 Yes III: Severe
8. Male 64 White 46 3 No HA: Moderate
9. Female 56 White 30 2 No liB: Moderate
Average 67.78 47.33 3
RESULTS
Six-Minute Walk Test
The results of the 6MWT are shown in Table 4.2. The repeated measures ANOYA test
demonstrated that subjects improved significantly on their 6MWT results (p < 0.01).
Subjects' mean walking distance in six minutes improved from 390 m, in the first evaluation,
to 500 m, on the second evaluation (see Figure 4.2). Thus on average, subjects improved
their walking distance by 110m. Eight out of nine subjects improved their walking distance
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by more than the threshold of 54 m for noticeable change. Overall the intervention
programme was successful in improving subjects' functional status.
Table 4.2. Results of the 6MWT
N. r" evaluation 2.0 evaluation Difference
1. 320m 420m 100m
2. 500m 610 m 110 m
3. 320m 420m 100 m
4. 510m 540m 30m
5. 510m 610m 100m
6. 470m 560m 90m
7. 120m 320m 200m
8. 550m 620m 70m
9. 200m 420m 220m
Min. 120m 620m 30m
Max. 550m 620m 220m
Mean 388.89 m 502.22 m 113.33 m
Standard 154.79 109.18
Deviation
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Current effect: F(1, 8)=32.111,p<0.01
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Figure 4.2. The difference in the mean distance walked by subjects in the 6MWT, pre- and
post-intervention.
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Baseline Dyspnea Index and Transitional Dyspnea Index
The single sample t-test was used to analyse the BDI and TDI. The TDI is a measure of
change from the BDI. Results showed that the average subject improved by five out of nine,
which is significantly higher than 0 (p < 0.01) (see Table 4.3). These results are highly
significant (p = 0,00003). This means that a high proportion of the sample group experienced
significant improvements in their levels of breathlessness after participating in the
intervention programme. All subjects had a score greater than zero.
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Table 4.3. Baseline and transitional dyspnea indices
BDI TDI
Minimum 3/12 +2/9
Maximum 8/12 +7/9
Mean 5/12 +5/9
Standard 1.98 1.51
Deviation
St George's Respiratory Questionnaire
Results of the SGRQ are shown in Table 4.4. Analysis of the SGRQ showed a statistically
significant change in the scores achieved by subjects on the SGRQ (p = 0.03) - although only
marginally significant with 0.03 nearing the 5% significance level. The mean score changed
from 54 (in the first evaluation) to 34 (in the second evaluation) out of 100 (see Figure 4.3).
A decrease in the SGRQ score indicates an improvement in HRQL. One of the seven subjects
measured had a positive change in her SGRQ score indicating a decrease in her HRQL
compared with six subjects who scored significantly lowered SGRQ scores on the second
evaluation compared to the first evaluation. The average subject decreased their initial
evaluation's SGRQ score by 20 points. According to the ATS (2002b:no page number) this
is a highly significant improvement in HRQL. The ATS (2002b:no page number) claims that
any change by four or more units indicates effective treatment. The exercise programme is
thus successful in improving COPD patients' HRQL.
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Table 4.4. Results of the SGRQ
N. 1st evaluation 2·d evaluation Difference
1. - - -
2. 37.06 28.63 -8.43
3. 24.87 13.72 -11.15
4. 49.78 51.98 2.2
5. 61.41 27.86 -33.55
6. 41.57 27.15 -14.42
7. 65.82 51.21 -14.61
8. 57.33 - -
9. 82.49 31.94 -50.55
Min. 24.87 13.72 2.2
Max. 82.49 51.98 -33.55
Mean 52.54 33.21 -18.64
Standard
Deviation
Least Squares Means
Current effect: F(1, 6)=7.8104, p=0.03
Vertical bars denote 0.95 conf idence interv als
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Figure 4.3. The difference in mean scores achieved by subjects on the SGRQ at pre- and
post-intervention evaluations.
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Forced Expiratory Volume in One Second
No significant changes were found in the subjects' lung function as was measured by the
FEVI. Results of subjects' FEVI are displayed in Table 4.5. The mean FEV(, as a percent of
the predicted value, stayed constant (see Figure 4.4) and the best value recorded for FEV I at
the second evaluation decreased slightly, but not significantly (see Figure 4.5). The mean
FEV I (absolute) decreased from 1.3 I to 1.2 I, a difference of 0.1 1. The largest change in
absolute FEV I was a decrease of 0.59 I, from 2.05 I to 1.46 I (the reason for this large
deterioration in lung function was not known). The largest change in FEV (, as a percentage of
predicted norms, was 29.75%, this was a subject who did not score well on other tests (this
subject was also a smoker and was unmotivated). The largest increase in FEV Iwas by 0.24 I
or by 8.99% as percentage of the subject's predicted norm.
Table 4.5. Results of absolute FEV Iand percentage of predicted FEV I.
Absolute FEVl (litres) Percent of predicted FEV 1(%)
N. 1st evaluation 2" evaluation Dier. 1st evaluation rd evaluation Diff.
1. 0.96 0.78 -0.18 31.33 25.69 -5.64
2. 1.67 1.7 0.03 56.77 58.37 1.6
3. 0.95 1.19 1.24 57.31 66.3 8.99
4. 1.22 0.89 -0.33 67.94 38.19 -29.75
5. 1.74 1.26 -0.48 46.8 34.2 -12.6
6. 1.82 1.93 0.11 63.44 68.15 7.42
7. 0.59 0.77 0.18 28.28 37.55 -9.27
8. 2.05 1.46 0.59 61.06 75.08 -14.02
9. 0.71 0.82 0.11 32.75 37.97 -5.22
Min. 0.59 0.77 0.03 28.28 25.69 1.6
Max. 2.05 1.93 1.24 67.94 75.08 29.75
Mean 1.3 1.2 0.14 49.52 49.06 -6.9
Std 0.53 0.43 15.21 17.91
Dev.
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Least Squares Means
Current effect: F(1, 8)=.01043, p=0.92
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Figure 4.4. The difference in subjects' mean lung function (as noted by FEV Ias a percentage
of the predicted value) at pre- and post-intervention evaluations.
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Figure 4.5. The difference in subjects' absolute mean lung function (as noted by the best
FEVImeasured at an evaluation) at the pre- compared to the post -intervention evaluation.
Stellenbosch University http://scholar.sun.ac.za
93
Patient Global Evaluation
Results of the patient global evaluation are shown in Table 4.6. The analysis showed a highly
significant change in subjects' score in the second evaluation compared to the first evaluation
(p < 0.01). Subjects' mean score improved from 45 to 66, a difference of 21 points (see
Figure 4.6).
Table 4.6. Results of the patient global evaluation
N. 1st evaluation 2·d evaluation Difference
1. - 60 -
2. 40 65 25
3. 55 75 20
4. 70 85 15
5. 50 80 30
6. 30 45 15
7. 50 80 30
8. 30 40 10
9. 30 60 30
Min. 30 40 10
Max. 70 85 30
Mean 44.38 65.56 21.88
Standard 14.5 15.75
Deviation
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Figure 4.6. The difference in mean scores on the patient global evaluation at pre- compared
to post-intervention evaluations.
Physician Global Evaluation
The results of the physician's global evaluation are displayed in Table 4.7. The physician's
global evaluation showed a significant increase (p < 0.01). Subjects' mean score improved
from 3.4, on the first evaluation, to 5.5, on the second evaluation (see Figure 4.7). The mean
improvement was 2.1 on the physician's global score.
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Table 4. 7. Results of the physician global evaluation
N. lit evaluation 2·d evaluation Difference
1. 2 4 2
2. - 5 -
3. 5 6 1
4. 2 5 3
5. 4 7 3
6. 5 6 1
7. 3 5 2
8. 2 6 4
9. 4 5 1
Min. 2 4 1
Max. 5 7 4
Mean 3.38 5.78 2.13
Standard 1.3 0.88
Deviation
Least Sq lS"es MeErlS
CLI"rert effect: F(1, 7)=28.493, p<0.01
Verticalta"s clerde 0.95 confidence irtenas8~----------r-----------------------T---------~
1
7 .
...................................................... ···········································T··
O~----------~----------------------~--------~
ewluation 1 ewluation 2
Figure 4. 7. Graph showing the difference in mean scores on the physician global evaluation
at pre- compared to post-intervention evaluations.
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DISCUSSION
Subjects' functional status (6MWT), breathlessness (BDI and TOI), physician global
evaluation and patient global evaluation improved significantly. All subjects experienced
great improvements in their levels of breathlessness after participating in the intervention
programme. However, it is unclear whether this improvement is due to subjects'
desensitisation to increased levels of dyspnea or as a result of reduced oxygen demands by the
working muscles after exercise training. The large improvements in the patient global
evaluation means that subjects had enhanced perceptions of their current health status after
exercise training. The increased physician's global evaluation scores means that the physician
also rated the subjects' health as significantly better than it was before the rehabilitation
programme.
Functional status improved largely in most subjects. A study by Berry et al., (1999: 1252)
reported significant improvements in functional exercise capacity of severe, moderate and
mild groups of COPO patients after their participation in an outpatient rehabilitation
programme. Although Berry et al., (1999:1252) differed from the present study in that the
group with severe COPD made the smallest in gains, with the moderate group making more
than twice the gains of the severe group. In the present study the largest increase in distance
of the 6MWT was made by the subject with the most severe COPD. She improved by 200 m.
The smallest improvement in functional status was measured in a subject who was a heavy
smoker (40 cigarettes a day), she only increased her walking distance by 30 m compared to
the sample group's average of 110 m. The same subject did not experience notable changes
in HRQL when compared to the rest of the sample group who experienced much larger
improvements. Bendstrup et al., (1997:2805) found a large improvement in COPO subjects'
6MWT of 113.1±10.4 (mean+standard error of the mean) metres after 12 weeks of pulmonary
rehabilitation, "which is larger than the improvements reported in other studies" (Bendstrup et
al., 1997:2805). The average increase in 6MWT in the present study was 110 m which is
close to the good results recorded by Bendstrup et aI., (1997:2805).
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Although there was not a large statistical difference in the SGRQ, the test is known to be very
sensitive to changes in COPD patients' HRQL and a small change in patients' score indicates
noticeable change in HRQL. Thus the statistically significant change in SGRQ represents a
significant improvement in subjects' HRQL. A recent study by Brooks et al., (2002:21)
found a 35% improvement of HRQL post-rehabilitation as was measured by the SGRQ and
the chronic respiratory disease questionnaire (CRDQ). The results of the present study's
SGRQ improved by an average of 20% which indicates that there is a need to adjust the
intervention programme in order to gain the improvements that were proven possible by
Brooks et al., (2002:21). Insignificant changes in HRQL from the baseline to the follow-up
evaluation were recorded by Berry et al., (1999: 1250). Berry et al., (1999: 1251) mention
that:
"these results are unique in that previous studies have shown pulmonary rehabilitation,
which includes exercise training, to result in improvements in physical performance
and health-related quality of life primarily in patients with moderate or severe disease
but not mild disease."
The SGRQ scores were not measured for subjects one and eight due to communication errors
between the study leaders. However, the significant improvement of these subjects' 6MWT,
dyspnea indices, patient global and physician global scores indicated an improvement in their
overall health status which can be assumed to have significantly improved their HRQL.
Subjects' lung function did not change significantly. In fact there was a slight decrease in the
mean FEV 1. There is "general consensus that airflow and gas exchange are not enhanced by
pulmonary rehabilitation" (Holden et al., 1990:332). The lowered lung function values in this
study may be as a result of the progressive nature of COPD where there is a constant
deterioration of the lungs.
Body composition (BMI) did not change significantly after the rehabilitation programme. In
fact there was a slight decrease in the mean BMI. The average subject's BMI fell into the
category of 'overweight' - according to the ACSM (2000: 64). The reduction in overweight
subjects' BMI reduced their risk of obesity related diseases. Schols et aI., (1991 :695)
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concluded that the measurement of fat free mass is an important determinant of exercise
performance in patients with COPD. The present study, however, did not find a high
correlation between subjects' BMI and the distance they walked in the 6MWT.
CONCLUSION
Exercise in pulmonary rehabilitation is successful in improving COPD patients' functional
status. Exercise is also successful in improving COPD patients' levels of dyspnea, patients'
perception of their own health and the physician's perception of COPD patients' health.
Exercise does not change lung function in COPD patients although pulmonary rehabilitation
improves COPD patients' HRQL. In this study group BMI remained relatively constant on
average. Nutritional counseling is likely to complement exercise in the optimal management
of body mass in COPD patients. Overall the results in this study came to similar conclusions
as research in the past did. No study of this kind has previously been published in South
Africa. This research has confirmed that pulmonary rehabilitation can be successfully applied
to COPD patients in South Africa and potentially other developing countries too. Pulmonary
rehabilitation in South Africa can achieve similar benefits to those derived from pulmonary
rehabilitation in the United States of America and in the United Kingdom.
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CHAPTER FIVE: CONCLUSIONS
RESEARCH CONCLUSION
Exercise has multiple benefits for COPD patients. Exercise improves COPD patients' quality
of life and their ability to perform activities of daily life. The importance of COPD patients'
quality of life cannot be overemphasized. COPD is incurable and thus patients' focus is on
enhancing their remaining years of life. Currently medicine has only limited capacity to
improve the symptoms of COPD. Exercise complements medical treatment and gives COPD
sufferers an opportunity to enhance their ability to live each day to its fullest. Past research in
other countries had similar findings and now exercise has demonstrated to be a successful
component of pulmonary rehabilitation in South Africa too.
The success of the intervention programme suggests that these exercises should be included in
future pulmonary rehabilitation programmes. Pulmonary rehabilitation should consist of
aerobic exercise, walking (preferably) or cycling, at an intensity of 60 - 75% of maximum
heart rate for the duration of 20 - 30 minutes. Celli (2003a:no page number), the ATS
(1999: 1672) and Maltais el al., (1997:557) also agreed upon walking as a form of aerobic
exercise as walking is necessary for most daily activities. Aerobic exercise may be
continuous or intermittent - depending on the subject's exercise capacity. Clark (1994:276),
Mink (1997:no page number) and Cooper (2001:S671) were also in favour of the
accumulation of 20-30 minutes of aerobic exercise. The ATS (1999: 1672) also found
substantial benefits after COPD patients exercised at the same intensity (60-75% of maximum
heart rate) as the subjects in this study did. Strength training of the arms, legs and abdominal
muscles should be performed with one to three sets of 10 repetitions. An intensity of four to
six on the Modified Borg Scale should be used in strength training of COPD patients, as was
also successfully used in a study by Maltais el al., (1997:561). During the intervention
programme it was noticed by the study leaders that subjects experienced reduced heart rate
and breathlessness for the same resistance exercises at similar work intensities. Study leaders
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also noted that all subjects increased the weight of resistance and/or the number of repetitions
performed during the 12 weeks of exercise. Strength gains and reduced heart rate at similar
work intensities were not measured objectively but there was definitely a noticeable
improvement in all subjects. The improvement of arm strength is thought to have contributed
to subjects' enhanced ability to perform ADL's and an improved HRQL. The improved leg
strength is thought to have contributed to subjects' functional status and reduced dyspnea
during activities such as climbing stairs or walking uphill. Abdominal strength is related to
breathing efficiency, especially the Tranverse Abdominus muscle (which was focused upon).
Improved abdominal strength is theorised to enhance COPO patients' ability to inspire and
expire to fuller lung capacities. The Sternocleidomastoid muscle plays an important role in
inspiration at high lung capacities. Exercise three times a week in this study elicited positive
results. The optimal number of exercise sessions per week was confirmed in studies done by
Mink (1997:no page number), Ringbaek et al., (2000:153) and Cooper (2001 :S671). Overall
the exercise programme was successful but this cannot be attributed to one particular exercise
or another. It can only be supposed that the success of the programme is attributed to the
combination of all the exercises. Further research needs to be done to clarify the role of each
exercise.
The use of medication seemed to decrease after pulmonary rehabilitation. This was not a
variable that was objectively measured, but study leaders noticed that all subjects commented
on their reduced use of a bronchodilator in an average day and also that they did not need to
use cortisone as frequently as before. A few subjects said that they did not visit their doctor
as often as they had in the past and some subjects did not experience as many acute
exacerbations as they had in the past. This means that pulmonary rehabilitation has the
potential to reduce medical expenses and medical aid claims. The reduction in medical
expenses after pulmonary rehabilitation has been established in studies in countries other than
South Africa. The study did not scientifically investigated whether there is a reduction in
medical expenses but it was definitely a benefit that was mentioned by subjects on many
occasions throughout the intervention programme. It is recommended that two aspects of
pulmonary rehabilitation (doctor's visits and medication use) be objectively measured in
future studies of this nature in South Africa. Pulmonary rehabilitation has the potential to be a
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relatively inexpensive method of improving the HRQL and reducing the expenses of South
African COPO patients in a nation who can scarcely afford the medical attention required for
the optimal treatment of chronic illnesses.
Pulmonary rehabilitation is not practiced scientifically and in most cases it is not offered to
patients by specialists and general practitioners in South Africa. This study has shown that
COPO patients' participation in specially designed exercise programmes results in an
improvement in their QOL and functional status. It is thus important that doctors,
biokineticists and physiotherapists around our country be educated as to the benefits that
pulmonary rehabilitation has to offer. Patients need to be encouraged to join pulmonary
rehabilitation programmes by their physicians and doctors. Pulmonary rehabilitation
programmes need to be set up around the country where they are easily accessible for
patients, for example, in clinics, hospitals and gyms. It is thus important that the medical
society of South Africa be made aware of the current under-utilization of pulmonary
rehabilitation and its vast potential benefits. Specialists, general practitioners,
physiotherapists and biokineticists need to work as a team towards the more holistic and more
effective treatment of COPO patients in South Africa.
LIMITATIONS
In retrospect it was found that there were a number of errors in the research procedures. A
potential source of error may have been the inconsistency of subjects' use of a bronchodilator.
At the first evaluation, subjects' lung function was tested pre- and post-bronchodilator in
order to exclude the diagnoses of asthma. This meant that each subject received a
bronchodilator approximately 15 minutes before the 6MWT. At the second evaluation,
however, there was no regulation of the use of a bronchodilator as the need for diagnosis no
longer existed. This meant that subjects most likely had used a bronchodilator for their
morning dose and could have used a bronchodilator at any other (unrecorded) time before the
performance of the exercise test at the second evaluation. It is only known that subjects did
not use a bronchodilator within 15 minutes prior to exercise test of the second evaluation.
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The use of a bronchodilator 15 minutes before the pre-intervention 6MWT was likely to have
caused a slightly enhanced walking distance whereas the identical bronchodilator-enhanced
performance was not established during the post-intervention evaluation. Thus subjects
underachieved in the second walking test compared with the first. However, this error was
indeed a positive error as any improvement seen in the exercise test result was over and above
the bronchodilator-enhanced performance of the first evaluation. Thus the performance
improvements were underestimated rather than overestimated.
Subjects' daily routines were unmonitored throughout this study. It is possible that changes
in subjects' daily routines may have positively or negatively affected their performance in the
study. Abruptions in subjects' daily lives may have affected their ability to attend exercise
sessions or caused subjects to be more tired, for example. Positive changes in subjects' daily
routines may have included improved sleeping habits and an increased appetite which would
have had a positive influence on their exercise performance. Subjects were asked by study
leaders to avoid significant changes in their daily routines for the duration of the study.
Unfortunately it was not practical to control this completely for as long as 12 weeks when
working with patients on an out-patient basis.
Six exercise sessions of absence resulted in the exclusion of a subject from the study. In a
few cases, however, subjects were unable to avoid being absent from exercise sessions due to
acute exacerbations and other complications. In retrospect, the set number of six sessions was
not enough for the subjects who were in the later stages of COPD. This is a topic that needs
some more thought for future research in the same field.
Limitations occurred that were beyond the control of the study supervisors. One limitation
was the restricted times within which subjects could be tested. The other limitation related to
the availability of subjects who were to be tested. The intervention programme was three
months long so it meant that the entire data collection was stretched over a relatively long
time and thus a time limit was necessary for the study. Consequently the total number of
subjects in the study was fewer than hoped.
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The second evaluation was delayed in three cases for different reasons. One subject's second
evaluation was delayed by two weeks due to a fall she took which resulted in a severe
haematoma on her right knee. Her results, however, still showed a significant improvement
when compared to her first evaluation's results. The second subject delayed the second
evaluation by a week due to his vacation which extended over the date set for the second
evaluation. Another subject's test date was postponed by a week as he was suffering from a
chest infection at the time of the test date.
The fact that three of the subjects continued to smoke throughout the study was likely to have
had a significant effect on their results and the results of the study as a whole. It is most likely
that these subjects would have displayed increased improvements in their post-intervention
scores versus their pre-intervention scores had they been non-smokers. Due to smokers being
included in the study the subject group was not entirely uniform. However, both smokers and
non-smokers experienced improved results therefore the exercise programme can successfully
be applied to both groups of COPD patients.
FUTURE RESEARCH AND RECOMMENDATIONS
Home pulmonary rehabilitation is a topic in need of research in South Africa. The benefits of
pulmonary rehabilitation are many but home rehabilitation has potential to benefit COPD
patients even further. Home rehabilitation is likely to be preferred since it is more convenient
for the patients and patients can apply their training in daily life. Busch and McClements
(1988:469) feel that if a home-based exercise programme can be shown to effectively reduce
disability of patients with COPD, the benefits will be more accessible to more patients.
According to Busch and McClement (1988:469) the cost of delivering a home-based exercise
programme is also far less than a hospital-based exercise programme. Research needs to be
done to determine the feasibility of home pulmonary rehabilitation in South Africa.
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"Adherence is often a major problem for the patient with COPD" (Hodgkin et al., 1993:90).
Ketelaars et al., (1997:366) found in their study that COPD patients tended to revert to their
pre-rehabilitation sedentary lifestyles in the months following rehabilitation and according to
Celli (1999: 196), the effect achieved by training is lost after the exercise is stopped. Brooks
et aI., (2002:20) state that: "poor adherence has a detrimental effect on morbidity, mortality
and health care resources". According to Hodgkin et aI., (1993:90) remarkably few studies
have evaluated methods to improve the adherence of COPD patients to an exercise
programme. Research needs to be performed to determine the most effective means of
encouraging COPD patients to adhere to pulmonary rehabilitation programmes.
It is suggested that COPD patients who are smokers be excluded from studies or placed in
their own separate experiment group. This is because smokers do not achieve the same
benefits from therapy as non-smokers and it is possible that smokers will skew the data
incorrectly with their extreme test results.
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APPENDICES
APPENDIX ONE: PATIENT INFORMATION AND CONSENT FORM
PATIENT INFORMATION AND CONSENT FORM
The influence of pulmonary rehabilitation on the quality of life and exercise capacity of
patients with chronic obstructive pulmonary disease (COPD).
You are invited to participate in a research study which will determine the influence of a
rehabilitation programme on your quality of life and exercise capacity. The evaluations and
the rehabilitation process will be monitored and managed by professional persons.
You are aware that you suffer from chronic obstructive pulmonary disease (COPD) and that
your exercise capacity is limited. This is the reason you are requested to participate in this
study. It is important that you understand the reasons for the study and that you address all
your relevant questions to the doctor in charge. You are asked to inform your personal
physician of your participation in the study.
Aim of the Study
The condition known as COPD is an inflammatory condition of the airways which is
commonly noted by a wheeze and breathlessness. As a result of the breathlessness your
exercise capacity is limited and this leads to weakening of your muscles, especially of your
thighs. These muscle groups as well as the upper arm muscles must function in the absence
of complete oxygenation and thus they weaken continuously. This weakening limits you with
regards to everyday functioning and pleasure activities in which you would like to participate.
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The aim of the rehabilitation process is to strengthen these muscle groups and hereby improve
your exercise capacity - even though your lung function may not necessarily improve. The
rehabilitation programme will take place over 12 weeks on three of the five working days in a
week. Rehabilitation will take place under strict monitoring of Ms Jenny Brown, who will
encourage and motivate you to adhere to the programme. Smokers are not excluded from the
study, but they will be strongly encouraged to join a stopping-smoking programme offered by
Prof. Bollinger in the Medical Faculty. The study will be performed according to
international standards for medical research as is determined by the ICH guidelines for good
clinical practice and the statement of Helsinki.
Ratification ofthe project will be gained from the Ethics Committee of the Faculty of Health
Sciences of Stellenbosch University.
Requirements for Participation
Symptomatic COPD patients who have grade I and II levels of breathlessness according to the
SATS (South African Thoracic Society) will be allowed to participate. The grade of your
sickness will be determined by a lung-function test, a six-minute walking test and
measurements of your body mass relative to your height. If you are being treated with oxygen
at home and you significantly desaturate, in other words the saturation of oxygen in your
blood decreases, during the exercise, you will be required to train during the exercise
programme while using oxygen. If you show significant signs of right heart failure or if you
have left and right heart failure, you will be referred to your physician for treatment before the
rehabilitation programme can begin. Thus you remain in the care of your own physician.
Your physician's input with regards to acute exacerbations, hospitalizations and changes in
your treatment will form an essential part of the study. You are required to have transport to
the Department of Sport Science, Stellenbosch University and be contactabIe via telephone.
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Evaluation Day 1
You will arrive according to appointment at Prof. JR Joubert's consulting rooms at 7 Rattray
Lane, Stellenbosch. The consent form will be discussed with you and you will be given the
opportunity to sign your consent once you have been given the opportunity to ask any
questions. You will be given a clinical evaluation after which a standard inspiratory and
expiratory lung function test and ECG (heart evaluation) will be performed. In the procedure
you will have to blow into a lung function apparatus. A six-minute walking test will be
performed which you will do with encouragement from a technologist. Your oxygen levels
and pulse will be monitored during the test. You may do the walk test by walking a little and
resting and walking and resting etc for the duration of the six minutes, it will be done within
your exercise capacity. The grade of your sickness will be discussed according to the points
system of the SATS 's guidelines for COPD. General tips with regards to the disease, the
presence of complications i.e acute exacerbations, the steps that will be taken, and your
communication with your physician, will be discussed.
Rehabilitation Programme
You will report to the Department of Sport Science, Coetzenberg, to meet with Ms Jenny
Brown by appointment. The rehabilitation process will be explained and demonstrated to
you. A questionnaire called the St George's Respiratory Questionnaire, will be completed
which will confirm your quality of life and the extent of your limitations based on your
history. You will participate in the rehabilitation programme individually or within a group.
The exercise programme will be on three of five week days and will last a minimum of 12
weeks. Each session will last approximately one hour. You will be excluded from the study
if you are unable to participate in the I2-week programme uninterrupted. Your presence at
the rehabilitation programme (according to appointment) is very important and your
participation in the study will be ended if you cannot attend more than six of the
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appointments. Goals will be set and you will be encouraged to reach them. The exercise
programme will be adjusted according to the extent of your limitations. Your progress will be
determined from your own baseline exercise capacity and you are not competing with anyone
else in your group. The exercise programme consists of walking exercises and muscle
strengthening with the help of biokinetic apparatus. As each patient joins the programme they
will be divided into two groups. The one group will be given a home programme, about
which they will be required to write a weekly report. The second group will follow their
normal home programme. The aim ofthis is to be able evaluate the patients again six months
after the exercise programme has ended in order to determine how many individuals in the
group were able to maintain their fitness level. If you suffer a temporary exacerbation of your
disease symptoms, you will not participate in your daily exercise programme and you will be
asked to consult your physician for are-evaluation.
Evaluation Day 2
After completion of the 12-week rehabilitation programme you will again complete the St.
George's Respiratory Questionnaire in order to measure your progress with regards to your
quality of life.
According to appointment you will report to the practice of Prof. Joubert. The lung function
test (inspiration and expiration test), six-minute walk test, your grade of dyspneayou're your
body mass relative to your height will be measured again.
Evaluation Day 3
You will report again by appointment at Prof. Joubert's consulting rooms. The evaluation
that was performed initially will be repeated and the lung function test, the six-minute walk
test and grading of dyspnea will be repeated. Your body mass relative to your height will be
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measured again. Hereby your progress in the programme will be determined. You will be
referred back to your physician who will follow-up on your disease symptoms, acute
exacerbations and hospitalizations over the last six months.
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PA TIENT CONSENT FORM
The information above is explained to me (name
of relevant person) in a language I am fluent in. I have been given the opportunity to
ask all questions and all questions have been satisfactorily answered.
There has been no pressure placed on me to agree to participate and I understand that I
may stop with the programme without any penalisation.
Participation in the project does not hold any additional costs.
I AGREE TO PARTICIPATE IN THE ABOVE MENTIONED PROJECT
Signed /confirmed at On
of 20 .
Patient signature Witness signature
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DECLARATION BY RESEARCHER
I declare that
• I explained the information content of this document to .
............................................. ..(name of participant! patient).
• I encouraged her/him and gave her/him sufficient time to address me with any
queries.
• This conversation took place 10 English/Afrikaans and no
translator was used.
Signed at on 20 .
Signature of researcher/ researcher's represetantive Signature of Witness
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APPENDIX TWO: BASELINE DYSPNEA INDEX
Functional Impairment
No Impairment. Able to carry out usual activities and occupation
without shortness of breath
Slight Impairment. Distinct impairment in at least one activity but no
activities completely abandoned. Reduction in activity at work or in
usual activities that seems slight or not clearly caused by shortness of
breath.
Moderate Impairment. Patient has changed jobs and/or has
abandoned at least one usual activity due to shortness of breath.
Severe Impairment. Patient unable to work or given up most or all
customary activities due to shortness of breath.
Very Severe Impairment. Unable to work and has given up most or
all customary activities due to shortness of breath.
W: Amount uncertain. Patient is impaired due to shortness of breath, but
Grade 4:---
Grade 3:---
Grade 2:---
Grade 1:---
Grade 0:---
amount cannot be specified. Details are not sufficient to allow
impairment to be categorized.
X: Unknown. Information unavailable regarding impairment.
Y: Impaired for Reasons Other than Shortness of Breath. For
example, musculoskeletal problem or chest pain.
Magnitude of Task
___ Grade 4: Extraordinary. Becomes short of breath only with extraordinary
activity, such as carrying heavy loads on the level, lighter loads uphill, or running. No
shortness of breath with ordinary tasks.
___ Grade 3: Major. Becomes short of breath only with such major activities as
walking up a steep hill, climbing more than three flights of stairs, or
carrying a moderate load on the level.
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Moderate. Becomes short of breath with moderate or average tasks,
such as walking up a gradual hill, climbing less that three flights of
stairs, or carrying a light load on the level.
Light. Becomes short of breath with light activities, such as walking
on the level, washing, standing or shopping.
No Task. Becomes short of breath at rest, while sitting, or lying down.
Amount Uncertain. Patient has limited exertional capacity due to
shortness of breath, but amount cannot be specified. Details are not
sufficient to allow impairment to be categorised.
X: Unknown. Information unavailable regarding limitation of magnitude
of task.
Grade 2:---
Grade 1:---
___ GradeO:
W:
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Y: Impaired for Reasons Other than Shortness of Breath. For
example, musculoskeletal problem or chest pain.
Magnitude of Effort
Grade 4:---
___ Grade3:
Grade 2:---
Grade 1:---
Grade 0:---
Extraordinary. Becomes short of breath only with the greatest
imaginable effort. No shortness of breath with ordinary effort.
Major. Becomes short of breath with effort distinctly submaximal, but
of major proportion. Tasks performed without pause unless the task
requires extraordinary effort that may be performed with pauses.
Moderate. Becomes short of breath with moderate effort. Tasks
performed with occasional pauses and requiring longer to complete
than the average person.
Light. Becomes short of breath with little effort. Tasks performed
with little effort or more difficult tasks with frequent pauses and
requiring 50 to 100 percent longer to complete than the average person
might require.
No Effort. Becomes short of breath at rest while sitting, or lying
down.
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W: Amount Uncertain. Patient has limited exertional capacity due to
shortness of breath, but amount cannot be specified. Details not
sufficient to allow impairment to be categorised.
X: Unknown. Information unavailable regarding limitation of effort.
Y: Impaired for Reasons Other that Shortness of Breath. For example,
musculoskeletal problem or chest pain.
(Mahler et al., 1984)
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WORKSHEET TO BE USED FOR ASSESSMENT OF DYSPNEA
Dyspnea Recordings: Date: Patient's Initials:
FUNCTIONAL MPAIRMENT MAGNITUDE OF TASK MAGNITUDE OF EFFORT
Job
Housework, shopping
Leisure Activities, Gardening
Social Activities
Washing! Dressing
At Rest
i
Any Other !
I
BDI Score: 0-4 Functional Impairment: Magnitude of Task: Magnitude of Effort:
I
TOTAL: /12
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APPENDIX THREE: TRANSITION DYSPNEA INDEX
Change in Functional Impairment
___ -3: Major Deterioration. Formerly working and has had to stop
working and has completely abandoned some of the usual activities
due to shortness of breath.
Moderate Deterioration. Formerly working and has had to stop
working or has completely abandoned some of usual activities due
to shortness of breath.
Minor Deterioration. Has changed to a lighter job and/or has
reduced activities in number or duration due to shortness of breath.
Any deterioration less than preceding categories.
No Change. No change in functional status due to shortness of
breath.
Minor Improvement. Able to return to work at reduced pace or
has resumed some customary activities with more vigour than
previously due to improvement in shortness of breath.
Moderate Improvement. Able to return to work at former pace
and/or able to return to most activities with moderate restriction
only.
Major Improvement. Able to return to work at former pace and
able to return to full activities with only mild restriction due to
improvement of shortness of breath.
Further Impairment for Reasons Other than Shortness of
Breath. Patient has stopped working, reduced work, or has given
up or reduced other activities for other reasons. For example, other
medical problems, being "laid off' from work, etc.
___ -2:
___ -1:
___ 0:
+1:---
+2:---
+3---
___ Z:
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Change in Magnitude of Task
___ -3: Major Deterioration. Has deteriorated two grades or greater from
baseline status.
Moderate Deterioration. Has deteriorated at least one grade but
less than two grades from baseline.
Minor Deterioration. Has deteriorated less than one grade from
baseline. Patient with distinct deterioration within grade, but has
not changed grades,
No Change. No change from baseline.
Minor Improvement. Has improved less than one grade from
baseline. Patient with distinct improvement within grade, but has
not changed grades.
Moderate Improvement. Has improved at least one grade but less
than two grades from baseline.
Major Improvement. Has improved two grades or greater from
baseline.
Further Impairment for Reasons Other than Shortness of
Breath. Patient has reduced exertional capacity, but not related to
shortness of breath. For example, musculoskeletal problem or chest
pain.
___ -2:
___ -I:
___ 0:
+1:---
+2:---
+3:---
___ Z:
Change in Magnitude of Effort
___ -3: Major Deterioration. Severe decrease in effort from baseline to
avoid shortness of breath. Activities now take 50-100% longer to
complete than required at baseline.
Moderate Deterioration. Some decrease in effort to avoid
shortness of breath, although not as great as preceding category.
There is greater pausing with some activities.
-2:---
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0:---
+1:---
+2:---
___ +3:
Z:---
(Mahler et al., 1984)
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Minor Deterioration. Does not require more pauses to avoid
shortness of breath, but does things with distinctly less effort than
previously to avoid breathlessness.
No Change. No change in effort to avoid shortness of breath.
Minor Improvement. Able to do things with distinctly greater
effort without shortness of breath. For example, may be able to
carry out tasks somewhat more rapidly than previously.
Moderate Improvement. Able to do things with fewer pauses and
distinctly greater effort without shortness of breath. Improvement
is greater than preceding category, but not of major proportion
Major Improvement. Able to do things with much greater effort
than previously with few, if any, pauses. For example, activities
may be performed 50-100% more rapidly than at baseline.
Further Impairment for Reasons Other than Shortness of
Breath. Patient has reduced exertional capacity, but not related to
shortness of breath. For example, musculoskeletal problem or chest
pam.
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WORKSHEET FOR ASSESSMENT OF DYSPNEA
Transitional Dyspnea Index (TDI)
Dyspnea Recordings: Date: Patient's Initials:
FUNCTIONAL IMPAIRMENT MAGNITUDE OF TASK MAGNITUDE OF EFFORT
Job
Housework, shopping
Leisure Activities
Social Activities
Washing! Dressing
At Rest
Any Other
TOI Score: -3 - +3 Functional Impairment: Magnitude of Task: Magnitude of Effort:
---
TOTAL: /-9 - +9
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Instructions for Admistration of the Baseline and Transition Dyspnea Index
The objective of the Baseline and Transition Dyspnea Indexes is to measure the severity
breathlessness (sensation of breathlessness, shortness of breath) in symptomatic patients.
The Baseline Dyspnea Index (BOl) measure the severity of dyspnea at the beginning of a
trial and the Transition Dyspnea Index (TOI) evaluates changes from this baseline
(transition period). The test is applicable to patients with dyspnea on exertion or at rest
due to respiratory disease. Administration of the Index should be undertaken before any
lung physiologic measurements on the test day and the interveiwer must be blinded to
other parameters evaluated for this patient.
The Dyspnea Indices were devised such that grading breathlessness could be performed as
part of obtaining a history from the patient. The indices include the categories Functional
Impairment, as well as Magnitude of Task and Magnitude of Effort which provokes
breathlessness. The interviewer asks specific questions based on the criteria of the various
grades of impairment or change in the mentioned categories. This approach was selected
instead of a questionnaire answered by the patient himself in order to allow an interviewer
with medical training or background to grade breathlessness in a simple and brief encouter.
The BOl as well as the TOI are composed of the three categories mentioned. The BDI
includes five grades of severity from zero (severe) to four (unimpaired) and the categories
are summed to create the focal score (zero to twelve). The TDI ranges from minus three
(major deterioration) to plus three (major improvement) including a zero score to indicate
"no change". Also for the TDI the three categories are added to obtain a focal score
ranging from minus nine, including zero, to plus nine. Provision is made for circumstances
when dyspnea cannot be rated: in the BDI, score "w" if no information, or "Y" if the
patient's capacity is compromised by factors other than respiratory. In the TOI, score "l"
if reduction of activities, effort or functional impairment is caused by reasons other than
respiratory .
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An interviewer, who should be experienced in history taking for respiratory disease,
administers the test. The interviewer should be a physician, nurse, respiratory therapist,
cardiopulmonary technician or have similar qualification with advanced knowledge or
training concerning dyspnea in respiratory disease. Evaluation and scoring is performed
during the interview and needs the same level of experience. It is preferred that the same
person conducts all evaluations for each patient.
The initial question addressed to the subject should be "Do you experience shortness of
breath?" If the subject answers "No", then the interviewer should ask whether any
physical activities cause the subject to experience breathlessness. If the answer to the
questions is "Yes", then additional questions follow to achieve the specific grading.
Questions concerning the patient's shortness of breath should be open-ended, and
concentrate on how the shortness of breath affects hislher daily life, e.g. the maintenance
or upkeep of residence, gardening, or shopping. The interviewer should focus on the
specific criteria for the severity of breathlessness as specified in the indices and the patient
should be rated based on the responses to the questions. The interviewer circles one
answer in the index that best describes how the patient's daily activities are affected by
hislher respiratory disease.
The interview process at each visit (baseline and follow up) should not take longer than
five minutes.
At the Baseline Visit (HDI)
Functional Impairment:
The first component focuses on finding out which types of everyday life functions at home
or in hislher job the patient is still able to perform. Are there any activities that he has had
to give up or change due to his shortness of breath compared to the level of activity before
the onset of his respiratory disease? (e.g. can he/she mow the lawn or do house work, can
he/she climb the stairs to the office or apartment as previously, can he/she walk uphill or
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cycle as previously, can he/she do the shopping, can he/she dress him/herself, can he/she
care for the pet?). It is important that the interviewer takes notes of the types of activities
and the attached form may serve as an example (not part of the CRF) of a record of the
identified events that can be referred to at follow up visits for the TOI. Circle the grade of
impairment in the BDI.
Magnitude of Task:
The second component focuses on the level and extent to which the individual tasks can be
performed until breathlessness is noticed. Again, it is important to record the level in the
form to be able to compare at follow up visits. Ask which activities make the patient feel
breathless (e.g. to what extent can he/she do the daily household chores, can he/she mow
30sqm lawn or how large is it, can he/she cycle on ground level, gentle slopes uphill,
moderate slopes uphill, which distance can he/she walk). Provide the examples of the
various grades and then circle a grade for magnitude of task.
Magnitude of Effort:
The third component focuses on the level of effort (exertion, vigour) that can be invested to
perform the individual tasks. Again allude to individual tasks and define the effort that
makes a patient feel breathless (e.g. shortness of breath only with extraordinary effort
.when mowing the lawn, or can just be done at normal pace, or can do it very slowly, or
need many pauses, can do the house work as rapidly as usual, or takes much longer than
previously, or need many pauses). Again, it is important to take notes of examples and
patient's description to be able to assess changes at follow up visits. Provide the examples
of the various grades for the magnitude of effort from the index and circle one.
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At Follow-up Visits (TDI)
The TOI measures change from the baseline state in the three categories. The interviewer
refers to his records of the individual patient's reported activities that result in
breathlessness, their magnitude of the task required to evoke breathlessness, and the effort
of performance possible. The record sheet and grades from the BOl serve as references
and for reminding the interviewer as well as the patient of his/her selections before
selecting a grade from the TOI. At each follow up visit the interviewer refers back to the
BOl and his original records and not to the previous TDI.
Change in Functional Impairment:
Review with the patient his/her functional status and the types of activities performed as
recorded at baseline. Ask the patient it there are any changes or modifications in his/her
activities since the baseline visit (e.g. has he/she given up or taken on activities). Select a
score from the index based on these changes, or circle zero if unchanged.
Magnitude of Task:
Review the level, i.e. magnitude of the specified activities that cause breathlessness. Ask
the patient which level now causes breathlessness and if there is any change from baseline
(e.g. can he/she climb less or more flights of stairs, can he/she walk longer or less, can
he/she walk steeper or less steep slopes than recorded at the baseline visit?). Select a grade
from the index considering that a change of plus/minus one should indicate the minimum
that can be recognised by the patient, a plus/minus three means a major change and
plus/minus two means any change in between.
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Magnitude of Effort:
Review with the patient the effort (exertion, vigour) he/she was able to perform at baseline
with the recorded activities until he experienced breathlessness. Ask the patient how much
effort no causes breathlessness and whether there is a change from baseline (e.g. does it
take more or less time for a certain activity, does he/she need to take less or more pauses
and can he perform with more or less effort (exertion, vigour)?). Circle a grade for change
in the index or select zero ifno change.
(Key Reference: Mahler et al., 1984)
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APPENDIX FOUR: A GUIDE TO ADMINISTERING THE SGRQ
What is the St George's Respiratory Questionnaire?
The St George's Respiratory Questionnaire (SGRQ) is designed to measure "health-related
quality of life", that is the impact of chest disease on daily life and well-being. Asthma,
chronic bronchitis and emphysema can cause major disturbances to daily life, which vary
from person to person regardless of lung function.
How should it be administered?
The questionnaires should be completed in a quiet room and the patient should be sat at a
desk or table. If the spouse had accompanied the patient try to separate them. It is
important that the patient completes the SGRQ themselves, without any advice from their
partner.
Explain to the patient why they are completing the questionnaire, and how important it is
for us to understand how they feel about their illness and the affect it has on their day-to-
day lives. The SGRQ is designed as a supervised self-administered questionnaire. This
means that the patient should complete the SGRQ themselves but someone must be
available to give advice if it is needed.
Ask the patient to complete the SGRQ as honestly as they can and stress that there are no
right or wrong answers, simply the answer that the patient thinks applies to them best.
Explain that they must answer every question and that someone will be close at hand to
answer any quenes.
Do not let the patients take the SGRQ home to be completed. It is important that it is done
in the presence of the investigator and that you can be sure it is answered by the patient
alone without the help of his/her family.
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What should I do about queries?
Answers to some possible queries are given in the guide to completing the SGRQ; beneath
each question. Read through this before seeing the patient. It is worth being prepared.
If the patient asks you to help them answer a question, don't give them an answer. The
point of quality of life questionnaires is to get an understanding of how the patient views
his/her illness. Simple readdress the question back to them.
Questions may be read out to patients who have difficulty in reading, but the responses
must be theirs alone.
What should I do when the SGRQ has been completed?
Once the patient has completed the questionnaire read through to check that each and every
question has been answered. Don't send the patient away before you have done this. If
any questions have been left unanswered, point them out to the patient and ask for answers.
If you see an answer that you disagree with, e.g. the patient ticks that he/she coughs a few
days a month, and you know that they cough more often, do not question its accuracy. By
asking a patient "are you sure this is right?", you are more or less telling them that you
think it is wrong. Since you are the expert, they may change their answer to agree with
you even though they still may feel that their first answer was right.
Finally thank the patient for their time and again stress how important and useful this
information is.
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ST GEORGE'S RESPIRATORY QUESTIONNAIRE
PART 1
Questions about how much chest trouble you have had over the last year. Please tick
in one box for each question.
most days several a few days only with not at all
a week days a week chest
a week infections
I) Over the last year I have coughed: D D D D D
2)Over the last year, I have brought
0 D 0up phlegm (sputum): D D
3) Over the last year, I have had
shortne ss of bre a th: D D D D 0
4) Over the last year, I have had
attacks of wheezing: D D D D 0
5) Over the last year, how many severe or very unpleasant attacks of chest trouble have
you had?
more than 3 attacks 0
3 attacks 0
2 attacks 0
I attack 0
no attacks 0
6) How long did the worst attack of chest trouble last?
(Go to Question 7 if you have had no attacks)
a week or more B
3 or more days .
lor2days ·
less than a day 0
7) Over the last year, in an an average week, how many good days (with little chest
trouble) ha ve you had?
no good days 0
I or 2 good days ~
3 or 4 good days .
nearly every day is good .
every day is good .
8) If you have a wheeze, is it worse in the morning?
no O
yes D
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PART 2
SECTION I
H.ow w o u ld yo u describe yo ur chest c o n d it io n ? (Please tick in o n e b o x
TRUE
the m o st im p o rta n t p ro b le m that I have 0
causes me quite a few p r o b le m s 0
causes me a few p ro b Ie m s '" 0
causes n o p ro b le m 0
If y o u have ever had paid e m p lo y m e n t, please tick o ne o f these:
TRUE
my chest tr o u b le made me sto p w o rk 0
my chest tro u b le interferes with my w o rk o r made me
change my w o rk '" 0
my chest tro u b le d o e s n o t affect my w o rk 0
o n ly )
FALSEoooo
FALSEo
oo
SECTION 2: Questi.ons ab o u t what activities usually make y o u feel breathless these
days. Fo r each item, please tick either true o r false as it applies to y o u ,
TRUE
Sitting o r lying still 0
Getting w a sh e d o r dressed 0
Walking aro u n d the h o rn e 0
Walking o u ts id e o n the level. 0
Walking up a fl ig ht o f stairs 0
Walking hills , 0
Playing s p o rts o r gam es 0
FALSEooooooo
SECTION 3: S.ome m o re q u e s t io n s a b o u t y o u r c o u g h and breathlessness these days.
Fo r each item, please tick either true o r false as it applies t.o y o u ,
TRUE
My cough o r breathing disturbs my sleep 0
My co u g h makes me tired 0
My c o u g h hurts 0
I get exhausted easily 0
I am breathless when I walk 0
I am breathless when I bend o v e r 0
FALSEoooooo
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SECTION 4: Questions about other effects that your chest trouble may have on you
these days. Please tick either true or false as it applies to you.
TRUE
My coughing or breathing is embarrassing in public ........ O
My chest trouble is a nuisance to my family, friends or
neighbours 0
I get afraid or panic when I cannot get my breath '" 0
I feel that I am not in control of my chest problem 0
I do not expect my chest to get any better 0
I have become frail or an invalid because of my chest 0
Exercise is not safe for me 0
Everything seems too much of an effort 0
FALSEo
oo
D
D
D
D
D
SECTION 5: Questions about yout medication. If you are receiving no medication go
straight to section 6:
To complete this section please tick either true or false as it applies to you.
TRUE
My medication does not help me very much 0
I get embarrassed using my medication in public 0
I have unpleasant side effects from my medication 0
My medication interferes with my life a lot 0
FALSE
D
D
D
D
SECTION 6: These are questions about how your activities might be affected by your.
breathing. For each question, please tick true if one or more parts applies to you
because of your breathing, otherwise tick false.
TRUE
I take a long time to get washed or dressed 0
I cannot take a bath or shower, or I take a long time 0
I walk slower than other people, or I stop for rests 0
Jobs such as housework take a long time, or I have to
stop for rests 0
If I walk up one flight of stairs, I have to go slowly or
stop 0
IfI hurry or walk fast, I have to stop or slow down 0
My breathing makes it difficult to do things such as
walk up hills, carrying things up stairs, light gardening
such as weeding, dance, play bowls or play golf. D
My breathing makes it difficult to do things such as
carry heavy loads, dig the garden or shovel snow, jog
or walk at 5 miles a hour, play tennis or swim 0
My breathing makes it difficult to do things such as very
heavy manual work, run, cycle, swim fast or play
competitrve sports 0
FALSE
D
D
D
D
D
D
D
D
D
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SECTION 7: We would like to know how your chest trouble usually affects your daily
life.
Please tick either true or false as it applies to you because or your chest trouble.
(Remember that true only applies to you if you cannot do something because of your
breathing)
TRUE
I cannot play sports or games 0
I cannot go out for entertainment or recreation D
I cannot go out of the house to do the shopping D
I cannot do housework 0
I cannot move far from my bed or chair 0
FALSE
D
D
D
D
D
Here is a list of other activities that your chest trouble may prevent you doing. (You do
not have to tick these, they are just to remind you of ways in which your breathlessness
may affect you):
Going out for walks or walking the dog
Doing things at home or in the garden
Sexual intercourse
Going out to church, or place of entertainment
Going out in bad weather or into smoky rooms
Visiting family or friends or playing with children
Please write in any other important activities that your chest trouble may stop you
doing.
Now, would you tick in the box (one only) which you think best describes how your
chest affects you:
It does not stop me doing anything I would like to do D..
It stops me doing one or two things I would like to do D
It stops me doing most of the things I would like to do 0
It stops me doing everything I would like to do 0.
THANK YOU FOR FILLING IN THIS QUESTIONNAIRE. BEFORE YOU FINISH
WOULD YOU PLEASE CHECK TO SEE THAT YOU HAVE ANSWERED ALL
THE QUESTIONS
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APPENDIX FIVE: MEDICAL RESEARCH COUNCIL INDEX
Grading of Dyspnea
Grade I
Grade II
Grade III
Dyspnea on vigourous effort only
Troubled by inclines or when hurrying on level ground
Short of breath walking with others of similar age and physique,
even on level ground, do own shopping
Short of breath with mild activity; cannot walk one block or climb one
flight of stairs without stopping for breath.
Grade IV
Holden et al., (1990)
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APPENDIX SIX: THE EXERCISE PRESCRIPTION FORM
See the following page.
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PULMONARY REHABILITATION PROGRAM
EXERCISE PRESCRIPTION FORM
,
NAME: .
DAlE: I I I I I
BP: I I I I I
RHR:
Sa02:
Intensity Sets Reps RPB HR RPB HR RPB HR RPB HR RPB HR
Walking RPB 5-6 min.
< 85%HRmax
Shldr rolls 3 10
Shldr shrugs 3 10
Bicep cur1s 3 10
Shldr press 3 10
Sit to stand 2 10
PellÁc tilts 3 10
PellÁc lifts 3 10
Neck flexion 3 10
Stepping 3 10
Crunches 3 10
Pee. Pusll 3 10
Hip flex.&
knee ext. 3 10
Squats 3 10
Walking RPB 5-6 min.
BP I I I I I
RHR
Sa02
, :
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